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One of the fundamental goals of biological engineering is the harnessing of 
biological systems to produce desired products. Protein production of exogenous 
proteins in living cells has long been a staple of molecular biology. However, living 
biological systems present fundamental limitations as the scientists’ desire to produce 
more complex and varying molecules in cells competes with normal cell processes. 
Ideally, one can isolate the required cell pathway away from the living system in order 
to explore the full range of possible molecular permutations allowed by chemistry 
without the limitations of biology. In vitro protein production allows life’s central 
dogma to be performed outside the confines of a cell, creating the possibility of 
producing toxic proteins and testing full mutation spaces in the DNA-RNA-Protein 
pathway. This possibility also opens up the need for materials to interface with genes 
and protein in an in vitro platform. Our lab has engineered a DNA gel that interacts 
with the gene-of-interest to increase protein yields while protecting the gene from 
degradation. DNA has long been investigated as a genetic material, but only in the pat 
decade has its vast potential as a generic polymer been elucidated. Beyond its 
monodispersity, the specificity of binding interactions in Watson-Crick base-pairing 
allows a unique level of control over structure and material organization at the 
nanoscale. In creating networked DNA structures that can incorporate genes into the 
gel network, we create protein-producing gels. However, further engineering of DNA 
gels is required in order to produce a system more comparable to the morphology and 
functionality of a cell, notably the isolation of gene sets and the ability to connect 
genotype and phenotype when testing protein activity. This thesis work discusses 
methods to create cell-size DNA gels that possess the ability to both produce and 
capture protein, practical considerations for DNA manipulation in cell-free protein 
production, and provides insight into further functionalization of DNA gels to provide 
more diverse applications in the context of protein engineering. 
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CHAPTER I: INTRODUCTION 	  
In this dissertation, I will demonstrate the versatility of DNA-based hydrogels 
as a platform for cell-free protein production. In the introduction, I will discuss how 
DNA can be rationally designed and how various applications beyond genetics emerge 
from the various engineered topologies. Furthermore, I will discuss cell-free 
expression and how this methodology has led to new capabilities in the testing and 
evolution of proteins. Next, I will explore the engineering of DNA as a material for 
hydrogels purposed for cell-free protein production. I will explain the design 
considerations needed for gel formation and protein expression, as well as how the 
DNA format allows for methods of functionalization. 
  
Section 1.1 - Introduction to cell-free protein production systems and directed 
evolution platforms 
 
 The engineering of biological systems can take many forms, with systems 
biology providing vast amounts of information gathered about signaling pathways1–3 
and synthetic biology creating novel pathways or branches from existing networks4–8. 
In the most general sense, biological engineers aim to gather information about 
systems in order to manipulate them to produce desired products. Much of this work 
makes use of prokaryotic cells, bypassing the complexities and environmental 
requirements of eukaryotes. 
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 Biomedical applications most often focus on eukaryotic systems, or the 
interplay between the prokaryotic realm and its influence on eukaryotic systems. Drug 
and gene delivery are vast fields, both academically and commercially, but yet the 
majority of bioengineering in the strictest sense takes place in prokaryotic systems. 
The presence of a nucleus in eukaryotes greatly complicates the ability to introduce 
foreign DNA and tap into existing cell pathways. On the other hand, prokaryotes 
readily take up plasmid DNA and have well-understood mechanisms for the 
replication of foreign DNA. The lack of a nuclear membrane also means there is direct 
access to the prokaryotic genome and that the machinery for transcription (the 
synthesis of RNA from a DNA template) and translation (the synthesis of protein from 
an RNA template) is present in the same solution volume as the rest of the cell 
processes. 
 Viewing the prokaryotic cell, especially the well-studied Escherichia coli (E. 
coli), as a natural compartment in which we can harness the power of biology has led 
to great excitement when considering the possibilities of bioengineering to address 
issues ranging from energy to materials production. In this manner, the cell is seen as a 
factory taking raw, simple molecules to produce more complex chemistries.  
 The study and engineering of the cell as a living factory has also opened up the 
possibility of further refining biological processes to more directly serve the needs of 
the researcher. A biological engineer aiming for more control of protein production or 
to utilize the cell to select for more desirable protein mutants can deconstruct the cell 
into its simplest components5,6 in order to focus on the specific pathway required for 
protein expression or synthesis of a molecule of choice9,10. In this manner, changes can 
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be introduced without restrictions imposed by a living cell – namely, the requirement 
to maintain a living, dynamic system. Yields of desired target molecules can be 
increased over in vivo production as there are no cells that require maintenance of 
processes extraneous to the desired task, and the energy supply and raw materials can 
be refocused towards the production of a protein of interest. Isolation and purification 
of the proteins is also less time-consuming, as the proteins are now in free solution 
rather than in the confines of cells that must be lysed. 
 In considering the format of such systems, it is straightforward to picture how 
cell-free protein production occurs – introduction of an expression plasmid into a cell-
lysate solution will induce expression of the gene. However, one can greatly expand 
the use of these systems by not only breaking them down into their basic components, 
but also engineering materials to mimic natural processes in this well-controlled 
environment. 
 There has been much work devoted to studying cell-free protein expression, 
but very little applies to the manner and state in which the DNA is presented to the 
cell’s enzymatic machinery outside a cell-based system. The accepted convention for 
cell-free expression is solution-phase expression, whereby the DNA for the protein of 
interest is simply added to the system either in a plasmid or linear gene-cassette 
format. Circular plasmid has been shown to have significantly higher expression than 
linearized gene, due significantly to the actions of nucleases that degrade DNA; a 
linear DNA strand possesses free ends that exonucleases readily attack. However, in 
considering DNA organization within a living cell, DNA is not truly a free-floating 
entity. 
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 DNA within the cell contains a level of organization that is not present through 
simple introduction of a plasmid to a solution. Even within prokaryotes, which do not 
possess a nuclear structure or the level of DNA organization found in eukaryotes, the 
DNA is normally found within a high-density region in the single large compartment 
of the cell. Though this is not true within all prokaryotes, as certain organisms have 
shown the presence of multiple linear or circular chromosomes11, it is true for most 
and importantly for the prokaryotic organism Escherichia coli (E. coli). In addition to 
the lack of a nucleus, most prokaryotes also do not possess histones, which are the 
proteins associated with wrapping eukaryotic DNA to condense the incredibly long 
genome into a small enough volume to fit into the nucleus. Rather, supercoiling 
provides another mechanism to package DNA. Regardless of the specific method of 
packing, DNA within cells is most often stored and accessed in a region of extremely 
high DNA density, whether it is in an actual nucleus of the eukaryotic cells or within 
the less defined ‘nucleoid’ of a prokaryote. 
 Though some forms of DNA immobilization have been used in cell-free 
systems, mostly in the form of gene immobilization, none have taken the steps to 
utilize DNA materials as a bulk organizer and scaffold. The ability to link gene-
encoding DNA into a larger material provides a means of organization and further 
functionality as the scaffold can be chemically modified, notably through thiol and 
click chemistry12,13. Such modification was performed in our lab to form DNAsomes, 
which form spontaneously through hydrophobic interactions from lipid-functionalized 
DNA14. 
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Section 1.2 – Engineering DNA materials 
 
 The structure of DNA was discovered and detailed in the 1950’s, but the 
enthusiasm surrounding this discovery was focused on the incredible potential this 
discovery held for genetics rather than the fundamental chemical and mechanical 
aspects of the polymer in chemical and material applications – and rightly so. 
However, if we remove ourselves from the realm of basic biology and genetics and 
view DNA as a generic polymer, it truly stands alone. There are a number of reasons 
DNA is a unique polymer for engineering materials at the nano- and microscale, and I 
will discuss how different DNA topologies can be created and used for different 
applications. 
  A single strand of DNA is comprised of a sequence of four monomer units – 
guanine (G), cytosine (C), adenine (A), and thymine (T). These nucleotides, or bases, 
can be encoded specifically into any sequence, creating complex sequences that are 
not readily achievable with other polymers; the number of distinct sequence 
permutations afforded by an N base strand is 4N. This would not be of great 
importance and use, however, if DNA existed only as a single polymer strand. Rather, 
its natural form is a double helix structure, with two strands bound to each other 
through hydrogen bonding (hybridization). In this manner, polymers can be 
synthesized to interact with each other in a controllable manner through sequence 
design. 
 Specific hydrogen bonding between strands occurs through Watson-Crick 
base-pairing, which is defined by the complementary base-pairing of adenine-thymine 
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(A-T) and guanine-cytosine (G-C). While adenine-thymine base pairing is conducted 
through two hydrogen bonds, the cytosine-guanine interaction occurs through three 
hydrogen bonds and thus provides a stronger associative force. This is an important 
consideration in DNA sequence design, as the degree of association between strands in 
a DNA duplex determines at what conditions, namely temperature, the strands begin 
to dissociate15,16. Furthermore, when a variety of different strands are being used in an 
experiment, the relative strength of interactions between strands becomes extremely 
important, as bases in a single-stranded DNA can also interact amongst themselves to 
form secondary structures that may interfere with the intended application. 
 The precise control of DNA length capable in synthesis, both naturally and 
synthetically, is a highly appealing aspect of DNA as a polymer for material 
applications and as a molecular organizer at the nano- and microscales. The 
monodispersity of biological polymerization processes, or ‘living’ polymerization, is 
extremely high when compared to other, bulk methods of polymerization, such as free 
radical or cationic/anionic addition17. This high degree of monodispersity allows for 
the controlled use of DNA at both small length scales, down to a few bases in length, 
and enormous aspect ratios when considering the approximately 2 nm diameter of 
double-stranded DNA. The stiffness of DNA also changes depending on whether it is 
being used in a single- or double-stranded format. The persistence length of a single 
strand DNA is approximately 2 nm while that of double-stranded is closer to 50 nm 
(≈150 base pairs)18. This broad difference allows us to design branched systems and to 
consider each arm as ‘stiff’, which gives excellent control over resulting topology. 
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 Our laboratory has created DNA-based materials over a range of applications 
using DNA in linear, branched, and network formats, as shown in Figure 1. Used in its 
more natural, linear format, DNA can be used as a coating ligand for nanoparticle 
assemblies. In coating nanoparticles with single-stranded DNA, particles interactions 
can be modified as the DNA seeks out complementary sequences coating other 
particle sets. Groups have recently used such capabilities to specifically encode 
crystalline structures with nanoparticles of different materials19–23, but our lab has 
focused mainly on the use of DNA to control gold nanoparticle crystallization 
conditions and spacing in solution24, on surfaces25, within free-standing sheets26, and 
at the water-air interface27,28. Even when complementary base-pairing is not utilized, 
DNA is an excellent coating ligand based on the precise control of length and 
monodispersity28. The inherent negative charge of DNA means that densely coated 
particles will not interact strongly at low salt concentrations, and while aggregation 
may occur at high salt concentration, crystallization occurs in a much smaller space of 
conditions. Monovalent and divalent salts will have also have vastly different effects 
on the system, as divalent salt possess the ability to ‘link’ strands together to increase 
effective interactions between particles28.  
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Figure 1: Formats of the various DNA topologies explored in the Luo laboratory. 
 
 As an engineered branched molecule, DNA structures present multiple arms 
that can be modified based on the application. Use of DNA in dendritic structures is 
particularly useful based on the extensive array of biochemical techniques that can 
interface with the nucleic acids29. The original pioneering work performed by Seeman 
and colleagues to produce branched DNA was based on the transient four-armed 
Holliday junctions formed during genetic recombination30. By constraining sequence 
symmetry, the first synthetic four-armed juncture was created and has led to the 
synthesis of a number of different branched morphologies31–36 as well as catenanes 
and knots37,38. Though early synthesis attempts were characterized by high 
conformational flexibility, crossover hybridization utilizing double, triple, and 
paranemic architectures led to more rigid and controllable structures. 
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Using the crossover hybridization technique, our lab has synthesized up to six-
generation DNA dendrimers39, and used such structures for the creation of a DNA 
barcode system40. Using green and red fluorescent moieties, branched DNA 
containing different ratios of these dyes were used for the multiplexed detection of 
various diseases40. Further functionalization of branched DNA that took advantage of 
the ability to carry different functional moieties on different arms yielded ABC 
(Anisotropic, Branched, and Crosslinkable) monomers41. The branches of this 
molecule were modified with fluorescent dyes, a UV-crosslinkable group, and a sticky 
end that was complementary to a target DNA or RNA. In the presence of the target, 
the ABC monomers were brought together by hybridization with the target, allowing 
for UV crosslinking into larger DNA aggregations observable under an optical or 
fluorescent microscope.  The ability to organize multiple functional groups on a 
branched molecule has applications across many fields, including drug delivery42,43, 
molecular sensing44, and DNA logic systems45. 
 Networked DNA structures can be formed through a number of mechanisms, 
but the most direct route is through the linking of branched DNA. Our lab synthesized 
X-, Y-, and T-DNA that were subsequently used as crosslinkable monomers and 
covalently linked by DNA ligase (Figure 2)39,41,46,47. In order for the branched 
structures to recognize other DNA monomers in solution, each arm possesses a 
palindromic sticky end that allows for hybridization. Though our lab covalently ligates 
these DNA units together, ligation is not required for bulk gelation; longer sticky ends 
can be used to ensure hybridization is strong enough at room temperature to maintain 
the gel morphology48. However, the direction and application of this thesis work 
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necessitates the use of both short sticky ends and ligation. The production of discrete 
gels in solution is needed in conjunction with the ability to crosslink DNA encoding 
for proteins into a growing gel network. As the method of recognition between 
monomers is based on sticky end sequences, other DNA and RNA displaying this 
sticky end can also be ligated into the network when digested by selected restriction 
enzymes. This is the unique aspect of DNA as compared to other polymers – the 
interactions that induce formation of the material are of the same type that allows 
interaction with exogenous DNA and RNA targets. This ability naturally makes DNA-
based materials a great platform for sensing and capture applications, as our work on 
DNA nanobarcodes has demonstrated40,47.  
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Figure 2: Different branched DNA structures can be crosslinked to form a 
hydrogel. Note the Y- and T- shaped DNA utilize three different single-stranded 
DNA sequences while X-DNA utilizes four46.  
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This ability to naturally crosslink DNA encoding for proteins of interest into a 
larger DNA network led to the formation of the our lab’s gel known as P-gel, or 
protein-producing gel49,50. When placed into cell-free lysate with the enzymatic 
machinery necessary for transcription and translation, the protein yield associated with 
the crosslinked gene was significantly higher than if the same amount of gene had 
been placed in a conventional setup, consisting of free genes in solution (Figure 3). 
This phenomenon is discussed further in Chapter 2, and is the basis for using the DNA 
gel format as a platform for developing further cell-free protein production 
technology. 
 
	  
Figure 3: Comparison of protein production between P-gel and solution-phase 
(SPS) setups. (a.) SDS-polyacrylamide gel shows successful production of Rluc 
and AcGFP protein using P-gel in lanes 2 and 4, respectively. (b) P-gel 
demonstrated significantly higher protein yields when compared to SPS controls, 
as seen in fluorescent images of the reactions volumes49,50. 
 
Our laboratory has explored other methods of DNA gel formation that do not 
involve ligation of branched monomers. Rather than utilizing covalent linkages to 
maintain a gel format, these gels are synthesized based on non-covalent interactions of 
long strands of single- and double-stranded DNA interwoven at a very high density. 
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The mechanisms behind the synthesis of these materials are varied, where one uses 
thermostable, branched primers formed by psoralen crosslinking51, and the other 
utilizes a modified rolling-circle amplification (RCA) procedure52. Interestingly, the 
material produced through the modified RCA process produces a network of high-
density bird nest DNA structures that are held together weakly by relatively few DNA 
strands to form a mechanical metamaterial52. This structure makes these high-density 
regions amenable to separation into discrete microgels. Aspects of this process are 
explored further in Chapter 4 in regards to opening further areas of DNA materials to 
applications in cell-free protein expression. 
  
Section 1.3 - Cell-free expression of proteins 
 
 The most significant advantage of in vitro protein production is the ability to 
produce and analyze a much larger mutation space than in a comparable cell-based 
process. In this thesis, I do not focus on the ability of cell-free systems to produce 
large quantities of protein, as cell-based methods have been optimized to such a large 
degree and incorporated into industrial processes so thoroughly in the last few 
decades. Rather, I focus on the concept of using DNA materials to reproduce the 
minimal level of cell function necessary to conduct directed protein evolution, as not 
only is transformation and cloning not required in such a non-living system, but 
proteins that would normally be harmful or toxic to a cell can now be produced 
outside of the cell using cellular machinary53. Certain molecules or proteins may not 
only affect the cell through the stress induced by the siphoning off of cell resources, 
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but directly through their molecular structure. This is especially true when utilizing the 
cell to produce exogenous proteins. Nonetheless, despite these limitations, the 
enormous potential of cell-based protein production can be seen in its widespread use 
across academia and industry. Traditional cloning work has been present for decades, 
and is taught as an essential lab technique for introducing plasmid DNA to cells54.  
 Cells naturally and beautifully possess the ability to isolate gene sets and 
maintain a genotype-phenotype connection, a feat that is difficult to reproduce outside 
of living systems. The genotype of a protein is the actual DNA sequence responsible 
for its production, while the phenotype is the physical manifestation or particular trait 
of that protein. This section provides a background on a variety of methods used in the 
evolution and engineering of proteins, but it is important to keep in mind that every 
method must address three key requirements: isolation of gene sets, sufficient 
(assayable) production of protein, and maintenance of a genotype-phenotype 
connection. 
 The potential to directly use biological systems to mutate and engineer proteins 
is perhaps most clearly seen in the synthesis of a range of fluorescent proteins from the 
naturally occurring green fluorescent protein (GFP). Small mutations in the DNA 
sequence of GFP led to the creation of an array of proteins possessing different 
excitation and emission spectra55,56. This has allowed for multiplexed labeling 
capabilities, which has been an extremely important development in the exploration of 
biological systems as different cell components can be tracked simultaneously and 
protein emission profiles can be refined to provide more accurate imaging57,58.  
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Since the initial works describing proteins as nature’s molecular machinery, 
significant efforts have been made to discover the sequence-structure-function 
relationship based in the amino acid sequence that constitute a protein59. As a greater 
understanding of this connection has evolved through the field of proteomics, the goal 
of modifying proteins to increase enzymatic efficiency or to create entirely new 
protein functions has led to different approaches to altering and testing different amino 
acid sequences, and necessarily the underlying DNA sequence. 
 Though the desired goal of producing proteins geared to a specific process or 
function may be conceptually straightforward, the methods to achieve this are less so. 
There are two inherently different approaches towards the engineering of proteins. The 
first method requires in-depth study of individual proteins, whereby enough 
information about the sequence-structure-function relationship has been deciphered to 
successfully allow for rational and selective substitutions, additions, or deletions in the 
amino-acid sequence. Advances in protein crystallization and the ever-increasing 
power of computing to sift through complex interactions at the nanoscale has allowed 
for this process to become more streamlined. Importantly, it has become extremely 
useful in increasing our understanding of protein structure and elucidating the effects 
of specific amino acid changes on conformation. However, this approach towards 
creating protein variants can prove to be extremely time consuming and resource-
intensive, and while contributing to basic knowledge of the proteins under 
investigation, it is often still very difficult to directly predict final enzymatic activity. 
This is especially true when mixtures of proteins act in concert with one another to 
produce synergistic interactions. 
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 Another promising and widely used method of creating proteins with increased 
efficiency or novel functions is the process of directed evolution60–65. This method 
involves the introduction of mutations into a gene (or within a targeted region of a 
gene), producing proteins from this library of mutants, and then subjecting the system 
to selective pressure to determine which mutated genes produce a protein with the 
desired activity. Thus, the experimental design is focused more on the material 
platform in which proteins are tested and in the manner in which selective pressures 
are instituted. The examples of changes in protein structure or activity that one can 
search for covers a wide range of potential characteristics, including higher enzymatic 
efficiency, catalysis, or binding constants to target molecules. 
 Cell-based methods for evolution have been used for decades to tailor the 
activity of proteins. For plate growth assays, enzyme activity is connected in some 
manner to the survival or growth rate of the cell stock. In this manner, only those cells 
transformed with a gene encoding a protein with the desired activity will grow on a 
plate or in media. Perhaps the most straightforward application of directed evolution 
research involves the tying of cell survival to the activity of a target protein. In this 
manner, cells that possess higher activity mutants will grow faster and outcompete less 
efficient mutants. In industrial scale production, growth media and feed is a major 
cost, and thus much effort has focused on the growth of cells on different feed sources. 
For example, testing for the breakdown of complex carbohydrates has been a useful 
method for biofuel applications65–76, whereby cells producing mutated cellulases are 
grown on a sugar-deficient media to select which cellulases most efficiently break 
down treated plant matter into simple sugars68,69,75,77. Such simple sugars then can be 
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reorganized into more complex molecules depending on the application, and further 
efforts are currently focused on industrial scale production of biofuels using cells 
evolved to act as biocatalysts for production65–68,71,74. These examples represent two of 
the main thrusts behind the evolution of proteins for industrial applications – to yield 
simple molecules from cheap, abundant feedstock for the repurposing of material flux 
to desired, and often more complex, molecules. 
Methods such as microtiter selection, most often performed with fluorescent 
products, have allowed for the testing of catalytic activity outside of those processes 
connected with cell survival78–81. However, this process severely limits the number of 
gene variants that can be tested; a high-throughput, automated system can still only 
test ≈106 variants, many magnitudes smaller than the potential library size82. Further 
advances have allowed for ultrahigh-throughput selection and analysis through 
methods such as affinity selection and fluorescence-activated cell-sorting (FACS). 
These methods allow for screening of binding interactions83–86 and fluorescence 
products82,87–93, respectively. 
 Though cell-based systems for directed evolution applications are widely 
accepted, there are certain disadvantages to selecting for protein mutations in a living 
system. Generally, when testing for protein phenotypes outside applications directly 
affecting cell processes, the use of living systems fails in the most basic regard when 
considering the requirements of testing a full mutation space. In order to produce 
mutations tailored to a specific function, the selection forces must only be specific to 
the activity of interest. In order to keep a gene in the selected set when using a living 
system, there is the additional requirement and selection pressure of maintaining or 
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increasing the growth of the cells. In most cases, the protein phenotype a researcher is 
seeking has an application outside cell growth, and thus this pressure proves to be 
extraneous and potentially disruptive to the experiment. When referencing potential 
sequence mutations, the term ‘beneficial’ mutation when testing in an in vivo system 
can often be describing an indirect measurement. As only genes that are maintained in 
live cells are selected for, the associated protein activity needs to be connected with 
cell-growth in some form (i.e. connecting products of an enzymatic reactions to an 
increase in metabolites), but certain protein mutations may spur cell growth without 
having a positive impact on the desired selection measure. On the other hand, 
beneficial mutations for the desired process can possibly decrease cell growth or prove 
to be toxic to the very cells that are serving as the platform for expression, testing, and 
evolution. 
 Based on these drawbacks, the ultimate goal would be to produce and test 
proteins without the needs of a living system. Before approaching such methods and 
my work, I first will introduce display systems that produce protein within a cell or 
virus, but yet allow for testing of the proteins on their associated surfaces. In this 
manner, the testing of proteins for activities other than catalysis and fluorescence has 
been expanded through the use of affinity selection, cell/phage display and yeast two-
hybrid systems. These methods have allowed for the evolution and modification of 
protein binding affinities. Binding affinity testing requires that the proteins of interest 
be expressed in a manner that allows them to interface with other surfaces or 
molecules outside the volume in which they are produced. In order to accomplish this 
task, cell-display employs the use of membrane localization signals in the form of 
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peptides attached to the C- or N-terminus of a produced protein. These signaling 
peptides induce incorporation in the membrane of the cell while displaying the protein 
of interest to the extracellular environment. Such displays have been demonstrated and 
used in many varieties of cells, including gram-negative bacteria94–96, yeasts97–100, and 
even mammalian cells when higher level post-translational modifications may be 
required101,102.  
 Phage display is a heavily-used technology in the study of protein-protein, 
protein-peptide, and protein-DNA interactions86,103–118. Bacteriophages are simple 
biological machines, containing a small DNA or RNA genome encapsulated by a 
protein coat. This protein coat is encoded within the phage’s small genome, and thus 
the sequence of the protein of interest can be added manually to this sequence. In this 
manner, binding affinities can be tested while maintaining a genotype-phenotype 
connection without the direct use of live cells in the assay. Phage display has been 
heavily used for antibody selection107,108,111,114,118, but has also led to improvements of 
protein stability110,115 and even the organization of non-organic materials on viruses119. 
Phage and cell display technologies are shown in Figure 4, and demonstrate the 
presentation of protein to the external environment. 
 Phage has also been used outside of protein binding applications as an 
infection mechanism for a novel continuous evolution platform. Phage-assisted 
continuous evolution (PACE) uses a ‘lagoon’ that contains a replication population of 
infectious progeny phage and E. coli120. Desired protein activities can be selected for 
as long as there is a method that ties protein activity to production of protein III, which 
is required for the viral infection of cells and production of more phage. In the 
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particular case tested, T7 RNA polymerase was evolved to express specific binding 
with the T3 promoter, which it normally will not recognize as a binding sequence. 
The drawback of all the methods listed thus far is that even if testing may take 
place using in vitro conditions, they still involve the use of living systems in one form 
or another. Viruses themselves are not considered ‘living’, but the process of gene 
library uptake as well as synthesis of new phage must occur through a cell 
intermediary; protein variants that are harmful to the cell may still be excluded from 
the final library by minimizing uptake and production of phage. In addition, there is 
still a needed transformation step, again limiting the size of the library significantly. 
Thus, even though the protein interactions are tested using in vitro binding platforms, 
many of the same fundamental problems surrounding undesired selection pressures are 
still found in phage display platform121.  
 The methods discussed thus far have allowed those both in academia and 
industry to begin to explore what mutations lead to optimized protein activity. In order 
to truly explore the full potential of evolution platforms, fully in vitro systems have 
also been developed that perform both cell-free protein expression and create a 
genotype-phenotype link. Figure 4 shows examples of creating this link: ribosome, 
mRNA, and DNA display. Ribosome display utilizes the suspension of the ribosome 
activity at the end of the translation process, halting the complex’s release of the RNA 
and associated protein, and thus leaving a physical connection between this translated 
protein and the mRNA template122–124. A similar method utilizes puromycin to 
covalently link an mRNA to the associated translated protein125–130. In this manner, 
binding assays can be performed on the protein while attached to the mRNA, and PCR 
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can be used to amplify the remaining nucleotide sequences in an assay after selection. 
The weakness of this approach is that there is only one protein associated with each 
mRNA. Phage display, on the other hand, can potentially display many proteins 
stemming from the same DNA sequence. 
	  
Figure 4: A comparison of display technologies for linking genotype and 
phenotype in selections involving binding target binding131.  
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 A different approach to creating a genotype-phenotype connection in a cell-
free expression utilizes compartmentalization as the gene isolation mechanism. In 
vitro compartmentalization (IVC) has allowed for an artificial connection between 
genotype and phenotype; researchers have produced and assayed proteins that are not 
directly bound to either a surface or the associated DNA/RNA90,92,132–138. Use of this 
method has been mostly been limited to processes that have involved either 
fluorescence or direct DNA/RNA-binding products due to difficulties associated with 
assaying132,136,138. The fact that expression and assaying takes place in the same 
volume requires that neither of these processes significantly interfere with each other. 
This severely limits the variety of assays that can take place using a pure emulsion-
based system. Another route to testing downstream binding interactions can be 
achieved through the previously mentioned DNA display, which is produced by 
binding protein to DNA within emulsion compartments. This emulsion-based gene 
isolation is the only current method by which DNA will associate only with the protein 
produced from its sequence. 
Certain groups have attempted to address the drawbacks associated with 
having to both produce protein and assay activity within the same volume by 
separating these steps through the use of microbeads in droplets. Using a multistage 
process, Swartz and Stapleton evolved a FeFe hydrogenase to be more oxygen 
tolerant92. However, the overall procedure required three emulsification steps. Their 
results show that although this method is possible and offers a path to high-throughput 
analytics, it is indeed quite complex and is not as straightforward is it may seem at 
first – library losses occur at each step as does potential contamination and crosstalk 
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between gene and protein sets. In images of the emulsions, they tend to be mixtures of 
heterogeneous droplets that may be prone to aggregation92. The approach does yield a 
more active FeFe hydrogenase in the presence of oxygen, but the platform is limited 
and relatively complex for more general applications. 
 Such work demonstrates that bead-based expression, whereby DNA or RNA 
for a protein of interest is bound to a nano- or microparticle and placed in a cell-free 
expression solution, has been attempted. Furthermore, the immobilization of DNA and 
RNA onto surfaces has effects on the overall protein yield in cell-free expression - the 
ability to induce non-specific binding in a region around DNA or RNA has been 
shown to localize expression machinery, thus increasing transcription and 
translation139. The method of securing the gene of interest to the particle is a critical 
issue. Binding of DNA to surfaces shows lower expression efficiencies than a 
corresponding SPS expression140–144, while attempts at localizing RNA shows 
drastically different results depending on the gene used and strength of binding 
interactions. Hamad-Schifferli specifically bound the RNA of eGFP and mCherry to 
nanoparticles through DNA-RNA interactions, and while certain binding conditions 
increased expression for mCherry, it actually reduced expression of eGFP139. The fact 
that these differences in expression are seen even with proteins as similar as these  
fluorescent reporters means potential differences among varying classes of proteins 
may be even more significant. 
Recruitment of translational machinery through nonspecific interactions to 
regions of localized mRNA has been shown to provide an increase in translation 
efficiency139,145,146. Through using DNA instead of RNA as the template, the P-gel 
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produced by our laboratory crosslinks high local concentrations of gene to induce 
increased transcription and translation. The negative charge associated with using 
DNA as the scaffolding material can induce nonspecific interactions with the proteins 
involved in transcription and translation. Other materials have been used to induce gel 
formation in the presence of DNA, including agarose and alginate. However, our lab 
work has shown that these polymers actually reduced protein expression rather than 
increasing it. 
 Another material that has been shown to provide benefits for cell-free protein 
production is clay. Our lab has demonstrated that clay strongly binds DNA in solution, 
offers protection against DNAse and RNAse degradation, and increases the protein 
yield of luciferase protein147. The specific mechanism for this process was not 
analyzed heavily, but it demonstrates that the interaction of DNA, RNA, and proteins 
associated with cell-free protein production interact differently and specifically with 
different scaffolding materials. Yields are based on a complex combination of factors, 
where enzymatic recruitment, but also DNA and RNA protection, are perhaps the 
leading factors concerning the gene template. 
  
Section 1.4 - Significance of this dissertation 	  
 The engineering of biological systems can take many forms and cover a wide 
variety of disciplines. They usually involve the use of natural, cell processes as a 
starting point for engineering higher molecular yields of particular metabolites, new 
cell pathways, or new proteins. In the case of protein production, cell-free synthesis of 
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proteins allows the focusing of energy and molecular flux towards the production of a 
protein of interest while removing the limitations on toxicity and cell stress induced by 
certain proteins. Protein labeling is more efficiently performed as direct control over 
amino acid makeup, including non-natural amino acids, can be exerted148. The range 
of proteins that can be produced, and thus, evolved from a cell-free system is 
dramatically greater than in cell-based systems. 
 Though cell-free protein synthesis sounds like the ideal platform for protein 
production, one loses the all-important genotype-phenotype connection that a cell so 
elegantly provides. In addition, though purification of the protein may be less time-
consuming than cell-based systems, one still must go through common methods of 
purification, notably flow-through nickel columns. Lastly, although strides have been 
made in cell-free protein synthesis and the use of these systems for directed evolution, 
low yields and application-specific nature of these works have limited their use. 
 This dissertation provides insight into the potential of DNA materials to 
address fundamental needs in cell-free protein synthesis by creating a material that can 
both produce and capture protein. From this, there is the potential to create an artificial 
genotype-phenotype connection in a high-yield protein-producing platform. The use of 
engineered DNA gels offer the ability to naturally interface with DNA and RNA in a 
way that is not possible with other polymers. Furthermore, versatile functionalities can 
be introduced by either modifying the ends of engineered branched DNA structures or 
introducing molecules that actually intercalate and covalently bind the DNA double-
helix. 
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 In Chapter 2, I will discuss the synthesis of a microfluidic setup to produce 
cell-sized DNA gels and the method used to retrieve these gels. Chapter 3 will review 
the practical considerations associated with engineering X-DNA for gel production 
and protein synthesis. This includes the testing of different sticky ends to modify 
interactions between the X-DNA structures and how selection of a plasmid 
linearization site affects cell-free protein expression. Chapter 4 discusses different 
methods of modifying cell-free lysate and DNA gels to increase the platform’s 
functionality. I first present the modification of the cell lysate and DNA to allow for 
protein capture, both in the P-gel format and in another form of DNA gel studied by 
our lab termed DNA bird nests, and then discuss a method of modifying the DNA to 
increase gel thermostability. 
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CHAPTER 2: SYNTHESIS OF DNA GEL MICRODROPLETS 	  
Section 2.1 - Moving from bulk gel to microgels 	  
 The synthesis of bulk DNA gels through the crosslinking of branched DNA 
monomers has been studied previously in our laboratory46. In the process of exploring 
applications of this DNA gel format, genes were ligated into this bulk gel to form the 
material P-gel, or ‘protein-producing gel’49,50. This gel was shown to increase gene 
expression significantly in cell-free lysate, many times over commercial solution-
phase systems. The mechanism behind this process involves protection of the genes 
from enzymatic degradation and the significant enhancement of transcription, leading 
to an increased concentration of mRNA compared to a solution phase setup. 
 The protection of genes within this gel may stem from multiple causes, but at 
least one mechanism is clear. The capping of the gene ends through X-DNA reduces 
exonuclease degradation, and the simple addition of a large excess of DNA that is not 
associated with gene activity further reduces nuclease activity on the genes. This leads 
to longer reaction times, up to three times longer than solution phase, and the ability to 
reuse the gels with additional lysate. As mentioned, another extremely important effect 
of the gel was the approximately 73-fold increase in mRNA levels over the solution 
phase system. The mechanism for this significant increase was not intensively studied; 
however, the results speak to a promising leap forward for cell-free protein 
production. 
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 The bulk P-gel format provided insight into using gel as a platform for cell-free 
protein production, but further work needed to be performed to scale this process up, 
make gel formation more consistent and reliable, and explore further functionality 
offered by a this networked DNA material. In this section, I will detail the 
microfluidic production of DNA microgels. This production provides a method to 
scale-up P-gel production while synthesizing homogenous gel structures that can be 
manipulated and processed as ‘cell’ structures based on their small size. This stands in 
contrast to earlier P-gel work, where gel molds of precursor solution were further 
broken up through pipetting of the gel solution. This leads to gel pieces that are 
heterogeneous in size and potentially gene constitution. 
 
Section 2.2 - Microfluidic device fabrication and testing 	  
 In order to produce homogenous, cell-sized gel droplets, gelation must occur 
within a small confined volume. Water-in-oil emulsions as well as liposomes and 
vesicles provide an ideal microcompartment, and have previously been used as 
reaction vessels129,131,141–144. However, most bulk methods for emulsion formation 
produce size distributions that would lead to heterogeneous gels. Extrusion methods to 
reduce heterogeneity are taken after initial emulsification has occurred, and thus 
would disrupt gel formation as ligation begins immediately upon mixing with X-DNA 
subunits. 
The use of microfluidics to produce large yields of highly monodisperse 
emulsions provides a platform in which to synthesize microscale DNA gel droplets. A 
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microfluidic device was designed that used a flow-focusing junction to allow for the 
production of water-in-oil emulsions152,153 using three inputs: one input for the outer 
oil phase, and two inputs for the inner aqueous phase to allow for separation of X-
DNA and ligase into separate precursor solutions154. The production of the device was 
undertaken through conventional photolithography processes, whereby a silicon 
master mold was created and from which PDMS replicas could be made. The first step 
in this process was a CAD design of the microfluidic layout. Two designs were 
eventually used in this project, but I will elaborate on the procedure for the first design 
as only the layout was changed for the second (the CAD layout and dimensions are 
different). The first design is shown in Figure 5A, demonstrating that two channels 
serving as aqueous inputs meet just before crossing over a third channel that will be 
carrying an oil flow. This double-junction design serves to pinch off the aqueous flow 
into water-in-oil droplets whose size depends on the ratio of flow between the aqueous 
and oil phases as well as the channel size where the flows meet. This relationship is 
shown in Figure 6 and Figure 7. 
The CAD design was transferred to a chrome-glass mask using the Heidelberg 
Mask Writer DWL66 at the Cornell Nanoscale Science and Technology Facility 
(CNF). Following developing of the mask, a silicon wafer was coated with a 40 µm 
layer of the negative photoresist SU-8 (Microchem, Newton, MA). Prebaking was 
performed at 90°C for three minutes, and then contact-mode photolithography was 
undertaken using a Mask Aligner (ABM, Scotts Valley, CA) and UV shield to protect 
from the smaller wavelength tail of the 365 nm mask aligner output. A 40 second 
exposure was used, followed by a five minute post-bake at 95°C and three minute 
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developing step. Lastly, the dried wafer was heated at 110°C for five minutes to 
further harden the SU-8 pattern. 
The SU-8 negative pattern master-mold was complete at this point, but in order 
to ensure the continued use of the mold after many repeats of PDMS casting, the 
hydrophobicity of the wafer was increased through molecular vapor deposition of 
(perfluorooctyl) trichlorosilane (FOTS). The wafer was first plasma oxidized, then 
coated with FOTS that serves as an anti-stiction layer, which reduces damage to the 
SU-8 pattern during removal of PDMS molds. After this deposition, degassed PDMS 
(placed under vacuum for one hour at room temperature) was poured on the wafer and 
heated at 70°C for four hours. 
After the PDMS hardened, individual devices were cut off of the wafer. 
Vertical inlet and outlet holes were punched into the PDMS to allow for inflow and 
outflow pins to be inserted, and then the device and a PDMS-coated glass slide were 
plasma oxidized and bonded. Incubation in a dry chamber overnight ensured the 
secure bond between the two components. This entire production process is 
summarized in Figure 5. 
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Figure 5: Overview of the microfluidic device construction154. 
	  
 The resulting emulsion and gel sizes based on input flow rates are shown in 
Figure 6 and Figure 7. The inputs for the device are also described, with one input 
containing X-DNA and gene and the other containing the ligation components, 
including ligase, ligation buffer, and excess ATP. However, after performing initial 
work with this microfluidic setup, it was noted that debris kept getting caught within 
the double junction and restricting flow; this required constant evaluation and device 
manipulation should flow be affected. We were able to dislodge most obstructions, but 
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this highlighted the need for filters within the device to ensure one could leave the 
setup running for long periods of time. Thus, we changed the microfluidic design to 
incorporate filters at each input, with the flow encountering parallel 50 µm channels 
followed by 10 µm channels before meeting other inputs. Being that the smallest 
channel width after this point is the 15 µm, found in the aqueous channels, there 
should not be any debris or gel aggregations large enough to clog the device at the 
flow junction. Figure 8 shows the in-device filters consisting of a two sets of a parallel 
series of size-exclusion channel. In addition, a redesigned double junction is shown 
with a smaller channel width than the previous device setup.  
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Figure 6: Overview of P-gel microdroplet expression154. (D) through (I) show flow 
under different ratios of aqueous flow versus oil flow. All scale bars are 100 µm.
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Figure 7: (A) P-gel droplet diameters for 35 µm channel width at 0.8 aqueous:oil 
flow rate ratio. (B) Relationship between P-gel droplet size and flow rate based 
on two channel widths154. 
 
	  
Figure 8: (A) Filters at the head of each input and (B) the double junction where 
aqueous inputs meet the oil phase. 
 
For production of gel droplets in the redesigned device, the flow rates used 
were 1.0 µl/min for the aqueous inputs and 6.0 µl/min for the oil phase. This gave a 
flow rate ratio of 3:1 oil:aqueous phase, given that there are two aqueous inputs. The 
resulting droplets are approximately 40 µm in diameter. Table 1 shows more detailed 
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information regarding the resulting gel sizes based on changes in the flow rate ratio. In 
looking at the aqueous inputs (Table 3), the addition of ATP beyond the 1 mM present 
in typical ligation reactions is to account for both the instability, and thus breakdown, 
of ATP during its residency within the syringe and the prolonged ligation necessary to 
form the networked gel. Thus, a final concentration of 1.5 mM was used, representing 
a 50% excess over traditional ligation buffers. 
 
Table 1: Mean diameter and standard deviation of DNA microdroplets using a 15 
µm channel width and either a 1:1 (oil:aqueous phase) or 3:1 flow rate. 
 1:1 Flow Ratio 3:1 Flow Ratio 
Mean (µm) 38.03 24.77 
SD (µm) 2.56 1.64 
 
Furthermore, we did not use stock ligase buffer as provided by NEB or 
Promega, but rather CutSmart Buffer from NEB. Table 2 shows a comparison between 
the two NEB buffers. This change in protocol was enacted due to the presence of DTT 
in the buffer, which can interfere with downstream applications of the gels. More 
specifically, protein capture applications can be significantly hindered, as DTT can 
reduce divalent cations that will participate in NTA-metal ion chelation common in 
His-tag binding. As there is no ATP present in the CutSmart Buffer, this component is 
added to reach the 1.5 mM used in the supplemented ligase buffer reaction. 
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Table 2: Comparison of buffers used for gel ligation. 
T4 DNA ligase Reaction Buffer (NEB) CutSmart Buffer (NEB) 
50 mM Tris-HCL 50 mM Potassium Acetate 
10 mM MgCl2 20 mM Tris-Acetate 
1 mM ATP 10 mM Mg-Acetate 
10 mM DTT 100 ug/mL BSA 
 
Emulsions were collected in a 1.5 mL tube, prefilled with approximately 100 
uL of mineral oil to reduce any droplet aggregation caused by collection in a dry tube. 
After collection, the droplets were incubated for 24 hours and then viewed under the 
optical microscope to check whether the gels had formed within the emulsions. 
 Droplet collection was performed by a rather rudimentary, but effective 
method. It has been found that the introduction of an electric field to a solution of 
water-in-oil emulsion droplets causes droplet instability by causing each emulsion to 
act as an individual dielectric as ions migrate to the their respective ends of the droplet 
based on the induced electric field155–158. Thus, to promote similar conditions, we 
transferred the emulsion solution from the 1.5 mL centrifuge tube to a smaller, 0.6 mL 
tubes and twisted the tube between our fingers with dry gloves for approximately one 
minute. We have made the conclusion that it is the static discharge from the twisting 
that causes the emulsions to break. The smaller diameter and larger surface of the 
smaller tube allows for more efficient breaking of the droplets. This conclusion is 
based on earlier experiments using both temperature changes and physical shaking to 
break the droplets; neither of these conditions effectively caused emulsion 
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aggregation. In addition, other methods such as hexane purification proved to be too 
harsh and often broke the DNA droplets apart. 
 To test the hypothesis that it is indeed the imparting of static charge to the tube 
that is inducing emulsion breakage, we plasma-treated a tube immediately before 
pipetting in a solution of water-in-oil emulsions. We compared this to a non-treated 
control tube and a tube on which the simple protocol previously described was 
performed. Figure 9 shows that compared to the non-treated control, the plasma 
treating and the ‘static’ charge breaking both separated the aqueous and oil phases 
significantly better. After breaking the emulsions and removing the oil now at the top 
of the solution, the microgels settle to the bottom of the tube, as seen in Figure 10. The 
gels were then collected, stained, and imaged (Figure 11) to confirm that they were 
synthesized from DNA and to view the porous structure of the resulting microgels. 
This porous structure should allow ample space for lysate diffusion into the gel. 
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Figure 9: From left to right, breaking of emulsions in (A) non-treated tube, (B) 
plasma-treated tube, and (C) ‘static’ treated tube. 
 
	  
Figure 10: DNA microgels settled at the bottom of the extracted aqueous phase. 
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Figure 11: P-gel microdroplets viewed under (A) optical microscopy, (B) 
fluorescence microscopy, and (C-D) scanning electron microscopy. Scale bars are 
all 10 microns154. 
 
Section 2.3 – Summary 	  	   The	  P-­‐gel	  format	  has	  previously	  been	  shown	  to	  increase	  protein	  yields	  in	  cell-­‐free	   expression,	   but	   was	   relegated	   to	   either	   a	   bulk	   gel	   format	   or	   use	   of	  heterogeneous	  gel	  pieces	  after	  mechanical	  breaking.	  Here,	  we	  show	  the	  process	  by	   which	   we	   produce	   homogenous,	   cell-­‐sized	   P-­‐gel	   microdroplets	   through	  microfluidic	   emulsions.	   A	   straightforward	   method	   of	   gel	   collection	   from	  emulsions	  is	  also	  shown,	  which	  allows	  for	  the	  production	  and	  gathering	  of	  a	  large	  number	  of	  gels	  in	  a	  short	  period	  of	  time.	  The	  small	  size	  and	  homogeneity	  of	  the	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microgels	   open	   up	   new	   applications	   in	   cell-­‐free	   protein	   expression,	   especially	  greater	  control	  over	  gene	  isolation	  in	  mutant	  library	  testing.	  	  
Section 2.4 - Materials and methods 	  
The oil used in these experiments was light mineral from Sigma-Aldrich, and 
was mixed with Abil-EM90 amphiphile (4% w/w) in order to allow for the stable 
compartmentalization of phases required for emulsion micelles. Before use, the oil-
amphiphile mixture was syringe-filtered through 0.25 µm cellulose to reduce potential 
clogging of the microfluidic device. Aqueous inputs to the device are listed in Table 3. 
 
Table 3: Aqueous inputs for the microfluidic production of P-gel microdroplets 
Syringe 1 Syringe 2 
X-DNA (300 µM) 83.33 µL NEB T4 Ligase (2,000 u/µL) 0.8 µL 
Linear Plasmid (1500 ng/µL) 15.53 µL Cutsmart Buffer (10X) 20 µL 
Tris-NaCl Buffer (10 mM) 1.14 µL ATP (10mM) 30 µL 
  NF-H2O 49.2 µL 
Total 100 µL Total 100 µL 
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CHAPTER 3: PROTEIN EXPRESSION – PLASMID AND X-DNA DESIGN 
 
Section 3.1 - Plasmid selection and linearization  	  
The ability of X-DNA to form a gel network is based on the covalent linking of 
monomers brought in proximity through attractive interactions induced by 
hybridization of single-stranded DNA sticky ends. Single-stranded DNA hybridizes 
specifically to opposing strands through Watson-Crick base-pairing, which is 
controlled through sequence design. In order to create conditions where each arm of 
the X-DNA can interact with any arm of an opposing X-DNA in a solution of identical 
X-DNA, the sticky end overhang must be palindromic. Additionally, self-ligation of 
X-DNA arms is minimized or eliminated completely by controlling the length of each 
arm. The double-stranded portion of each arm is 18 base pairs, well below the 
persistence length of dsDNA (≈50 nm, corresponding to approximately 150 bases), 
and thus the arms should remain stiff. The goal of crosslinking genes within this X-
DNA gel network limits the types and number of sticky ends that can be used – the 
overhang must be complementary to that produced by the restriction enzyme used to 
linearize the gene/plasmid. The majority of restriction enzymes produce four base-pair 
palindromic overhangs. 
 In the original P-gel work performed in our laboratory, the plasmid pIVEX1.3 
was used to express green fluorescent protein (GFP)49. This plasmid is optimized for 
expression in wheat germ lysate. However, my initial expression work was performed 
in E. coli lysate, as wheat germ lysate is significantly more expensive to purchase and 
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more time consuming/expensive to produce in the laboratory for initial work. At the 
time of this writing, E. coli lysate is cheaper when purchased commercially and is 
relatively straightforward to produce in the lab. Additionally, the decision to use E. 
coli became a matter of necessity rather than a cost consideration based on the need to 
make certain changes to the chemical makeup of the lysate, which will be discussed 
further in Chapter 4. For the purpose of this discussion, the takeaway is that a plasmid 
optimized for E. coli lysate was selected - pIVEX2.3d as supplied by 5’ Prime, Inc. 
 Whereas pIVEX1.3 was linearized with ApaI (5’ – GGGCCC – 3’), 
pIVEX2.3d does not contain this restriction site. Another site was needed that only 
presented at one location in the plasmid sequence and was not present in either of the 
cloned genes we would be expressing, GFP and mCherry. The AatII restriction site (5’ 
– GACGTC – 3’) was selected as it met these conditions, and additionally was not 
present in sequence regions near the promoter or terminator of T7 polymerase, which 
is responsible for the expression of the cloned gene. This reduces the chance that the 
digestion of the plasmid will affect expression. Figure 23 shows the location of the 
AatII restriction site. 
 There is a critical interplay between the restriction enzyme used for plasmid 
linearization and the resulting quality of P-gel, in regards to its physical appearance 
under bright field microscopy and its ability to withstand incubation under conditions 
associated with cell-free protein production. Though the details of these topics are 
discussed separately, the X-DNA design is dependent on the choice of restriction site 
because the linearized plasmid must find complementary sticky ends on the X-DNA. 
Restriction enzymes naturally recognize a broad range of sequences and produce a 
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variety of sticky ends, the majority of which are palindromic four base-pair overhangs. 
These overhangs vary in directionality (5’ vs. 3’ overhangs) and base makeup. In turn, 
sequence differences affect stability of hybridization, making them more or less likely 
to be ligated depending on the Gibbs free energy (ΔG) value of the particular sequence 
match. Thus, this description of hybridization stability affects the macroscale gel 
morphology, as higher ligation efficiencies yield a more highly networked structure. 
 This interplay between gel strength and sticky end choice explains why AatII 
was not selected as the restriction enzyme for linearization. Though the linearized 
plasmid displays expression in cell-free lysate, as in seen in Figure 18 and Figure 19, 
the overhang sequence does not allow for a robust gel to form within the time 
conditions used for ligation. The negative gel formation results elucidated the 
importance of overhang sequence in DNA gel formation even when ligation, and not 
strictly hybridization, is the method of network formation. Thus, in searching for 
another restriction site, the sites were limited to overhangs with a lower ΔG than AatII 
and at least comparable to ApaI. The details of this process are detailed in Section 3.3. 
The sites BspEI and NgoMIV were selected, although their locations within the 
plasmid were a cause for concern due to their close proximity to the T7 terminator 
(BspEI) and T7 promoter (NgoMIV). Though the sites are not within the associated 
sequences themselves, digestion of the plasmid nearby may negatively affect 
expression through two mechanisms. Firstly, promoter and terminator sequences 
induce conformational changes within the DNA to have their desired effect on 
polymerase159–163, and digestion of nearby DNA may interfere in this process. 
Secondly, and perhaps more importantly, linear DNA is prone to digestion by 
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exonucleases; the closer the gene itself is to the end of the linearized plasmid, the 
greater the likelihood that exonuclease will degrade the gene itself and lower overall 
expression. However, the details of this potential effect are not well understood, as the 
vast majority of gene expression is performed off of circular plasmids, and in those 
instances where linear genes are used, these design considerations are not deeply 
discussed. 
 The solution-phase expression levels for both BspEI and NgoMIV digests were 
significantly lower than that produced by AatII, as shown in Figure 19. Though this 
may not directly correlate with the expression levels from P-gel microdroplets, we 
wanted a linearization site that did not reduce solution-phase expression so drastically. 
The relative increase in protein yield provided by P-gels is much greater when using 
linear plasmids with minimal solution-phase expression, as the P-gel reduces 
exonuclease degradation of plasmid by ligating the free ends into a DNA network. 
Thus, an expression comparison was needed that compared the P-gel sample to a 
linear plasmid control that could express to a significant degree. Based on the resulting 
gel strengths associated with different sticky end sequences that will be discussed in 
Section 3.2, we made the decision to introduce the MluI restriction site into the 
pIVEX2.3d plasmid. 
 Since this restriction site was being introduced manually, we could search for a 
possible mutation site as far from the gene of interest as possible to minimize the 
effect of linearization on cell-free expression. Figure 23 shows the selected region on 
the plasmid, which was selected based on its position opposite the gene, the minimal 
two base change needed for MluI site introduction, and its spacing in between the 
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antibiotic resistance gene and the origin of replication. As both the pIVEX2.d-GFP 
and pIVEX2.3d-mCherry plasmids had already been created, we needed to perform 
this process separately on each plasmid. The primers used for the site-directed 
mutagenesis are detailed in Table 6. Digestions of the mutated plasmids were 
undertaken to ensure that the plasmids isolated from different colonies did in fact 
contain the MluI mutation. These results are shown in Figure 12. 
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Lane 1 Circular pIVEX2.3d-GFP 
Lane 2 AatII digestion of pIVEX2.3d-GFP  
Lane 3 MluI digestion of MluIpIVEX2.3d-GFP – Colony 1 
Lane 4 MluI digestion of MluIpIVEX2.3d-GFP – Colony 2 
Lane 5 MluI digestion of MluIpIVEX2.3d-mCherry – Colony 1 – GC Buffer 
Lane 6 MluI digestion of MluIpIVEX2.3d-mCherry – Colony 2 – GC Buffer 
Lane 7 MluI digestion of MluIpIVEX2.3d-mCherry – Colony 1 – GC Buffer + 
DMSO 
Lane 8 MluI digestion of MluIpIVEX2.3d-mCherry – Colony 2 – GC Buffer + 
DMSO 
 
Figure 12: 1.0% agarose gel showing testing of different colonies to ensure the 
plasmids isolated contained the mutated MluI site. PCR buffer conditions are 
also mentioned for the red fluorescent proteins, as they required changes to the 
traditional PCR mix.
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Based on the MluI digestion results, we selected colony 2 of GFP and colony 2 
for mCherry. However, after running cell-free expression experiments to confirm 
whether the plasmids were functional in SPS, we gathered positive results for 
MluIpIVEX2.3d-GFP but not for the MluIpIVEX2.3d-mCherry. This mCherry sample 
was selected because it was produced in GC buffer, rather than GC+DMSO buffer, 
and thus presented a smaller possibility of extraneous base mutations164. In regards to 
proclivity for mutations during PCR, the buffer choice in increasing order of potential 
for base mutations is as follows: HF, GC, and GC+DMSO. MgCl2 and DMSO both 
serve to stabilize base pair hybridization, and can potentially maintain an unstable base 
pairing long enough for it to be incorporated into the growing DNA strand. The main 
difference between HF and GC buffer is the inclusion of a higher MgCl2 
concentration in the GC buffer. As can be seen, HF buffer did not give positive results 
in the cases tested. Thus, only after colony 2 of GC mCherry was shown to have low 
expression were colonies 1 and 2 for GC+DMSO mCherry tested. 
 
Section 3.2 - Selection of red fluorescent protein 	  
Fluorescent proteins are often used as model or reporter proteins because their 
inherent fluorescence under UV excitation provides a direct and straightforward 
method of determining how much, and of which, protein has been produced. Green 
fluorescent protein is the most commonly used fluorescent reporter, and has been 
mutated many times over to create a large number of variants55,56. These variants have 
improved fluorescence properties in addition to having varied excitation and emission 
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spectra, producing different color signals to allow labeling and detection of multiple 
target simultaneously57,58. 
 The company 5 Prime supplied the expression plasmid pIVEX2.3d with an 
accompanying control plasmid containing GFP with a C-terminal 6His-tag. We could 
then express wild-type GFP without having to perform the cloning manually. Being 
that one of the goals of this work is to demonstrate that, in lysate, microgels can 
express their own gene set and capture a representative protein sample produced from 
those genes, we required another fluorescent protein distinctive from GFP. This would 
allow us to produce two sets of P-gel microdroplets, one containing genes for green 
fluorescent protein and another for red fluorescent protein, and then optimize 
conditions whereby each gel fluoresced predominately green or red. Such a result 
would demonstrate that proteins from the gene set within the gel had a greater 
probably of securing themselves to the associated gel than do proteins produced by 
other gels. This is based off the assumption that even if translation is occurring in the 
solution and not just in the gel itself, which was the conclusion based off of our earlier 
work50, the majority of mRNA in the immediate vicinity of each gel will be produced 
from the plasmids contained within. Thus, there should be a higher concentration of 
associated proteins in the volume surrounding the gel, leading to a representative 
display rather than simply an average of the larger solution volume. 
 There are many choices for red fluorescent protein, but in general red 
fluorescent proteins do not possess the same brightness as offered by green fluorescent 
proteins. At the beginning of this work, we would have selected Tdtomato based on its 
on its strong fluorescence signal compared to other red fluorescent proteins56. 
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However, selection of a reporter protein is made more complicated by the fact that 
cell-free reactions often lack much functional cellular machinery beyond those for 
transcription and translation; thus, more complex proteins often need modifications 
made to the lysate to allow for their organization even if it appears to be a small 
structural change. Tdtomato, for example, is supposed to have the strongest 
fluorescence output but is a dimer rather than a monomer, and this extra level of 
organization may not take place efficiently in the cell-free reactions. Thus, it was felt 
to be prudent to clone and test three different red fluorescent reporter proteins: dsRed, 
mCherry, and tdTomato. We performed Gibson assemblies to create three pIVEX2.3d 
vectors containing each of these three proteins. The primers associated with the 
production of the plasmid backbone for each Gibson assembly are shown in Table 6. 
Colony growth demonstrated that the cloning was indeed successful, and Figure 13 
shows the slightly different variations of red in the colonies 
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Figure 13: Colony growth showing the expression of various red fluorescent 
proteins in pIVEX2.3d 
  
 Figure 14 and Figure 15 demonstrate that mCherry provides the highest 
fluorescent signal after cell-free expression, using a 10 uL reaction with 100 ng of 
plasmid DNA. Selection of the mCherry as the red fluorescent reporter protein was 
based on this expression in cell-free lysate. 
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Figure 14: Fluorescence comparison between three red fluorescent proteins 
expressed in cell-free lysate using the pIVEX2.3d expression plasmid. 
 
	  
Figure 15: Solutions of (A) dsRed (B) mCherry (C) and tdTomato expressed in 
cell-free lysate and viewed through fluorescent microscope. 
 
Section 3.3 - Gel formation based on sticky end sequence 
 
Early P-gel experiments were performed using ApaI for the linearization 
digestion. This enzyme leaves a 5’ – CCGG – 3’ overhang sequence on the 3’ ends of 
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the resulting linearized double strand, and thus this sequence also was included on the 
3’ ends of each strand making up the X-DNA. The majority of restriction enzymes 
leave four base-pair sticky ends, which alone are not sufficient to induce gel formation 
through simple hybridization. The melting temperature of this base-pair matching is 
too low (<10°C) to form stable, temporally significant interactions, but they do allow 
for ligation to occur. This is in contrast to gels that form solely through hybridization 
interactions; such gels utilize overhangs of at least eight base pairs48.  
As plasmid considerations came into play, discussed in Section 3.2, we began 
to use AatII linearized plasmid that presented overhangs of 5’ – ACGT – 3’ on the 3’ 
ends of the double strand. Since we were not looking to create a gel through strong 
overhang hybridization but rather ligation, the base sequence of the overhangs was not 
initially considered critical to the design. However, microgel formation did not occur 
in emulsions using X-DNA with AatII overhangs, as shown in Figure 16. In order to 
maintain reproducibility in experiments, we held gel ligation times to 24 hours. 
Samples of AatII X-DNA left to ligate for significantly longer showed the ability to 
eventually form microgels, but it proved too long to use effectively and often varied 
between experiments. Within the 24 hour ligation time, gels were not seen in the 
solution extracted from emulsions or even in the emulsions themselves. After multiple 
attempts at attempting ligation at both 16°C, the optimal temperature for ligase, and 
4°C, to ensure greater hybridization efficiency, we were not able to achieve successful 
DNA gel formation using AatII overhangs. 
This stood in contrast to the work performed to synthesize P-gel microdroplets 
using ApaI-sticky end X-DNA. As compared to AatII X-DNA, gels produced using 
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ApaI sticky ends did form within emulsions, but had mixed results after extraction 
from the emulsions into pure aqueous phase. The gels tended to break up either from 
the extraction procedure itself or from pipetting and shaking, which is necessary for 
the cell-free expression. 
These results suggested that the overhang sequence was critical to gel 
formation. As the melting temperatures of these four base-pair overhangs are quite low 
(less than 10°C), it is useful instead to compare their Gibbs free energy of formation. 
The 3’ overhang of 5’ – ACGT – 3’ presented by AatII digestion possesses a ΔG of -
6.5, while the 3’ overhang of 5’ – CCGG – 3’ for ApaI digestion possesses a ΔG of -
9.28. This matches with the experimental results showing that ApaI overhangs 
produce gels within emulsions while AatII does not. AatII may not be stable enough 
over a time period long enough to be amenable for ligation, and thus although it is 
theoretically able to undergo ligation, gelation requires a high ligation efficiency that 
is not being achieved with the smaller ∆G value. 
 As AatII did not provide usable microgels, another restriction site was needed. 
In analyzing suitable restriction enzymes, BspEI appeared to match the requirements 
needed. However, the restriction site (5’ – TCCGGA – 3’) is significantly closer to the 
cloned gene in the plasmid, and although it lies just outside the T7 terminator 
sequence, it is sufficiently close to possibly affect expression. The 5’ overhang of 5’ – 
CCGG – 3’ provides a ∆G of -9.75 kcal/mole, and thus appeared to be a more suitable 
option for droplet formation than previous choices. Gel formation in emulsions was 
viewed, and in fact, the gels appeared to be more consistent in size, shape, and 
appearance than in the ApaI microgel sets. This can be attributed to the larger ∆G 
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value. Isolation from the emulsions also was successful, leaving behind full droplets 
and very little remnants and artifacts from broken droplets that could potentially 
interfere with protein capture further along in the experiment. The results of the gel 
droplet formation are shown in Figure 16, and corresponding bulk gel formation is 
shown in Figure 17. 
 This BspEI overhang gel seemed at first to be the solution to many of the 
problems plaguing gel formation and isolation, but another difficulty arose in the 
aforementioned location of the gene linearization. As seen in Figure 18 and Figure 19, 
cell free expression of pIVEX2.3d-GFP linearized with BspEI is lower than that 
provided plasmid cut with AatII. A greater amount of the linearized plasmid is needed 
to begin seeing signal significantly beyond background. It was considered beforehand 
that the close proximity of this restriction site to the T7 terminator may pose an issue, 
and indeed the proximity does negatively affect expression. 
Another cutting site was selected based on its production of the same 5’ – 
CCGG – 3’ overhang as BspEI. NgoMIV is present just in front of the T7 promoter; 
again, this is closer than we would be comfortable with, but went ahead in testing the 
expression of the plasmid digested with this enzyme. Proximity to the cloned gene, 
specifically to the T7 promoter, interfered with expression, as seen in Figure 19. 
It became clear that in order to take into consideration gel strength and 
expression efficiency, a restriction site would have to be added into the plasmid. Based 
on this manual sequence change, we had total control over what site we could use. 
Thus, we aimed to capitalize on the apparent trend seen in increasing gel robustness 
based on increasing ∆G value of overhang hybridization by analyzing the ∆G values 
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of all possible four base-pair overhang combinations consisting of 100% cytosine and 
guanine bases. For this analysis, we used the Oligoanalyzer Tool on the IDT® 
website165. As shown in Table 4, the 5’ overhang 5’ – CGCG – 3’ presents the largest 
∆G of -10.36 kcal/mole. With the physical data demonstrating significant morphology 
differences associated with small changes Gibbs free energy, this sequence was 
selected and introduced to the plasmid through site directed mutagenesis. The 
restriction enzyme MluI provides this selected overhang, and recognizes the sequence 
5’ - ACGCGT 3’. A site was chosen that required a two base mutation and was 
essentially directly opposite the cloned gene and not present in any of the other critical 
regions in the plasmid (origin of replication or ampicillin-resistance gene).  
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Table 4: Comparison of X-DNA sticky end overhangs, showing the enzyme 
recognition site, the resulting overhang, and the Gibbs free energy associated 
with the overhang hybridization. 
 	  
Table 5: Description of the different four base-pair overhangs used in the X-DNA 
design. 
4 Base Pair Overhang 
 
(Overhang Direction) 
Corresponding 
Restriction Enzyme Site Gel Result 
GGCC (3’ overhang) ApaI 
No bulk 
Gels in emulsion 
Poor extraction 
ACGT (3’ overhang) AatII 
No bulk 
No gels in emulsion 
(Not applicable) 
CCGG (5’ overhang) BspEI, NgoMIV 
Bulk 
Gels in emulsion 
Good extraction 
CGCG (5’ overhang) MluI 
Bulk 
Gels in emulsion 
Good extraction 
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Figure 16: Views of X-DNA droplets in emulsions and after extraction into bulk 
aqueous phase. The restriction site names to the left define the overhangs used on 
the X-DNA. 
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After cloning, transformation, and plasmid isolation, the gene was digested to 
ensure that the site was introduced, and then the linear plasmid was tested in cell-free 
lysate to ensure that expression was higher than shown with BspeI and NgoMIV 
plasmids (Figures 18 and 19). Synthesis of X-DNA microgels was performed under 
the same conditions as the previous gel-emulsions experiments, which were described 
in Section 2, and the results of the synthesis are shown in Figure 16. One can see that 
in both the emulsion and extracted aqueous phase, the microgels produced from MluI-
X-DNA appear to be robust and show little signs of break-up or fracturing. Based on 
the expression results and the strong gel formation using MluI, this X-DNA was used 
in the further experimental work on P-gel, including functionalization and expression 
work as discussed in Chapter 4. To ensure all X-DNA in these experiments was in fact 
being produced in high-yield and that results concerning gel formation were 
differences associated with X-DNA hybridization, we compared them on a 2.5% gel. 
Figure 20 shows that all X-DNA are being formed efficiently, and thus the overhang 
sequence is not affecting the efficiency of X-DNA hybridization. 
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Figure 17: Comparison of bulk gel formation using X-DNA possessing four (A) 
AatII, (B) ApaI, (C) BspEI, and (D) MluI overhangs. Concentration of X-DNA 
(52.5 µm) was set at that used for P-gel bulk production in earlier work49,50. 
Tubes E and F are gels created by BspEI X-DNA that has been psoralen-
crosslinked by 5:1 and 10:1 psoralen:X-DNA ratios, respectively. 
 
Cell-free expression from the MluI P-gel microdroplets was found to be similar 
to that found in a system containing approximately 20 ng/uL of linearized plasmid. In 
looking at the solution used for P-gel synthesis in Table 3, the final P-gel sample 
contains approximately 17 ng/uL crosslinked into the gel used in the reaction. The 
expression was shown to be the approximately the same as 20 ng/uL MluI-linearized 
plasmid expression, which represents an approximately 18% increase in protein yield.
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Figure 18: Cell-free expression comparison of GFP in droplets using different 
plasmid linearization sites. Solutions viewed were 1.0 uL and 2000 ms exposure 
with green UV filter was used. The expression vector is pIVEX2.3d linearized 
with (a.) AatII (b.) BspeI (c.) MluI. Each reaction was a 11.5 uL reaction 
containing 500 ng of vector. 	  	  
	  
Figure 19: Cell-free expression levels of pIVEX2.3d-GFP linearized at different 
restriction enzyme sites. 
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Lane 1 NEB LMW Ladder 
Lane 2 Oligo 4 of X-DNA 
Lane 3 ApaI X-DNA (modified X-DNA sequence) 
Lane 4 AatII X-DNA 
Lane 5 ApaI X-DNA 
Lane 6 BspeI X-DNA 
Lane 7 MluI X-DNA 
 
Figure 20: 2.5% agarose gel showing that all X-DNA with different sticky ends 
form in high yield. The modified X-DNA sequence for lane 3 is the sequence 
presented in Table 12 for psoralen-crosslinked X-DNA. 
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Figure 21:	   Cell-free expression of GFP in linear (MluI-digested) and circular 
plasmid formats. 
 
Section 3.4 – Summary 	  	   The	   work	   discussed	   in	   this	   chapter	   serves	   to	   elucidate	   the	   design	  considerations	   that	   are	   important	   in	   P-­‐gel	   microdroplet	   formation	   and	   gene	  expression.	   Though	   ligation	   is	   driving	   the	   crosslinking	   of	   X-­‐DNA	   to	   form	   a	  networked	  structure,	  the	  sequence	  of	  the	  four	  base-­‐pair	  overhangs	  is	  shown	  to	  be	  critical	   to	   final	   microgel	   strength.	   Furthermore,	   the	   restriction	   site	   used	   to	  linearize	  expression	  plasmid	  was	  shown	  to	  significantly	  affect	   the	  expression	  of	  protein	   in	   the	   solution-­‐phase.	   This	   is	   an	   important	   aspect	   of	   system	   design	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because	  P-­‐gel	  expression	  yields	  are	  compared	  to	  solution-­‐phase	  controls,	  which	  show	  drastically	  different	  expression	  based	  on	  the	   length	  of	  sequences	   flanking	  the	   gene	   of	   interest.	   Thus,	   the	   P-­‐gel	  microdroplet	   format,	  which	  minimizes	   the	  need	   for	   long	   flanking	   sequences	   by	   crosslinking	   the	   gene	   into	   a	   larger	   DNA	  network,	  is	  extremely	  useful	  for	  linearized	  vectors	  with	  low	  expression	  and	  gene	  cassettes	   that	   often	   just	   contain	   the	   necessary	   promoter	   and	   terminator	  sequences	  flanking	  the	  gene.	  	  	  
Section 3.5 - Materials and methods 	  
Protocol for preparing X-DNA 
The annealing process for synthesis of X-DNA from four oligos is shown in 
Figure 22. It requires a slow ramp down in temperature to ensure proper hybridization, 
and is performed in 10 mM Tris buffer with 50 mM NaCl at a 100 µM concentration 
of each strand. After annealing, the solution is concentrated in a 30 kDa MWCO 
column and washed in the 10 mM Tris with 10 mM NaCl. The solution of X-DNA is 
aliquoted and stored at -20°C for long-term storage and at 4°C for a working solution. 
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Figure 22: Four single-stranded oligos are annealed to form X-DNA. The colored 
segment in the (A) show sequence regions that are complementary154. 
 
Site-directed mutagenesis 
 Phosphorylated forward and reverse primers, shown in Table 6, were designed 
to incorporate a two base-pair change at the location of the new MluI site. PCR was 
performed using the Phusion® High-Fidelity DNA Polymerase from New England 
Biolabs® Inc., with protocol and buffer used according to kit instructions. Blunt-end 
ligation was performed following PCR to create circular plasmids that were then 
transformed into One Shot® Top10 Chemically Competent E. coli from Invitrogen™.  
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Figure 23: Plasmid map of pIVEX2.3d-GFP (left) and mutated MluIpIVEX2.3d-
GFP (right). The addition of the MluI site was performed at a site opposite the 
gene of interest and between other coding regions. 
 
Table 6: Primer sequences for different aspects of pIVEX2.3d manipulation. 
Sequencing  
Forward 5’ – TATAGGGAGACCACAACGGT – 3’ 
Reverse 5’ – AGTGTGCTGGAATTCGC – 3’ 
Gibson Template  
Forward 5’ - CAACCCGGGGGGGGTTC – 3’ 
Reverse 5’ – GGTATATCTCCTTCTTAAAGTTAAACA – 3’ 
MluI mutation  
Forward 5’ – /5Phos/GTAGTGGAACGAAAACTCACG – 3’ 
Reverse 5’ – /5Phos/GCGTCAGACCCCGTAG – 3’ 
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Cell-free expression reactions 
Reactions in cell-free lysate were prepared under the same guidelines as 
reported in literature, specifically in our lab’s P-gel expression work50. Briefly, 20 
ng/uL of linear plasmid was used in cell-free reactions while 10 ng/uL circular 
plasmid was used. This is based on expression tests shown in Figure 21 that 
demonstrate these gene concentrations lead to similar expression levels. More 
information regarding the specific solution makeup of the lysates are found in Table 9.
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CHAPTER 4: GEL FUNCTIONALIZATION 	  
Section 4.1 - Production of homemade E.coli lysate 	  
 Due to the large number of expression experiments that were necessary to 
optimize expression and capture conditions, it was necessary to produce my own 
E.coli lysate. The original procedure for this lysate production has been documented 
previously, and is shown in Table 9. This procedure is an abbreviated lysate 
preparation outlined by Kim et al166. It is important to note that the final lysate 
solution is actually created from two solutions – the actual lysate gathered from 
cultured E. coli, and a buffered reaction mixture. The lysate itself mainly contributes 
the enzymes necessary for transcription and translation, while the reaction mixture 
contains the chemical energy, nucleotides, amino acids, and other molecules necessary 
for transcription and translation to continue over an extended time period. The 
combination of these two solutions to form the final mixture is termed ‘lysate’ unless 
otherwise noted. 
 Production of homemade lysate was not only a cost consideration, but was 
essential based on the goal of protein capture. The most widely used method of protein 
capture is His-tag binding, where a 6-histidine tag (though shorter or longer repeats 
can be used) on the end of protein specifically binds a chelated divalent metal cation. 
As we intended to functionalize DNA gels to achieve this capability, which will be 
discussed in Section 4.2, we needed to ensure the solution supported this method of 
binding. Commercial lysate kits, and homemade lysate recipes, include DTT as a 
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means to reduce protein-protein interactions by disrupting disulfide bond formation, 
thus increasing potential reaction time. As His-tag binding is dependent on Ni2+ 
chelation by NTA, DTT must be removed as it can reduce the nickel ions and render 
the binding method unusable. Figure 24 demonstrates that in a control experiment 
whereby GFP-6His is incubated with agarose-NTA-nickel beads from Qiagen, the 
DTT concentration in the lysate is sufficient to cause little or no protein capture. In the 
same lysate without DTT, the beads show a significant fluorescent signal. 
 
	  
Figure 24: Agarose-NTA-Ni2+ gel beads incubated with GFP-6His in (A) 
traditional cell-free lysate and (B) cell-free lysate without DTT. 
 
 As a further consideration, in literature describing homemade lysate 
preparation the use of spermidine instead of PEG to increase solution viscosity has 
been shown to provide an increase in protein yield167. Viscosity-inducing reagents are 
necessary to create a more cell-like solution, aiding in the transcription/translation 
process166–168. Following the literature, we produced reaction mix with spermidine and 
saw a small increase in expression with circular vector (data not shown). However, 
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after attempting expression with P-gel microdroplets, gels were not present after a 6-
hour expression. After multiple repeats of this setup, we concluded that the spermidine 
lysate was in fact disrupting the gel morphology. Though we did not perform further 
work to determine the cause of this result, it was noted that spermidine is a positively 
charged amine at the neutral pH that cell-free lysate reaction takes place (this reaction 
mixture becomes slightly acidic as the reaction progresses). Both spermine and 
spermidine, molecules that have the same +2 charge and similar chemical makeup, 
have been shown to interact strongly with DNA169–171. We concluded that the large 
amount of spermidine in the solution was disrupting the structure of the P-gel 
microdroplets. 
 Based on these results, we again produced a reaction mix without DTT, but 
replaced spermidine with PEG 8000 as the viscosity-inducing reagent166. Figure 25 
shows that after incubation and shaking for six hours at 30°C, gel microdroplets are 
still visible and appear to be maintain their integrity as discrete, individual units with 
minimal aggregation. This is the solution that was used as the lysate solution for all 
lysate expression experiments in this thesis work. 
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Figure 25: Optical microscopy showing the effects of lysate incubation on P-gel 
microdroplets compared to their original morphology in storage buffer (10 mM 
Tris-NaCl). 
 
(A)	  Buffer 
(B)	  Lysate	  	  (spermidine) 
(C)	  Lysate	  	  (PEG) 
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Section 4.2 - NTA-functionalization of X-DNA 	  
 As documented in previous work49,50, DNA gel does not naturally possess the 
ability to capture, or aggregate, protein produced by the genes contained within. 
Protein isolation and purification from solution most commonly uses the specific 
binding of an N- or C-terminal His-tag to a chelated divalent metal cation such as 
nickel. This method of protein purification, whether that protein is produced through a 
cell-based or cell-free protein production method, is normally performed in a column 
format; columns provide access to immobilized nickel while allowing for constant 
flow. The nickel in these columns is chelated most often through a nitrilotriacetic acid 
group (NTA), though some commercial columns use a TALONTM metal affinity 
resin172–174. Chelated nickel, copper, and cobalt have all been shown to specifically 
bind his-tagged proteins, though with different affinity and specificity175,176. 
 In order to introduce a nitrilotriacetic acid group into the DNA, we needed to 
connect this molecule to a moiety that can interact with any of the chemical groups 
with which IDT could modify the 5’ or 3’ end of a DNA strand. Addition of a thiol to 
the 5’ end of an oligo we use to construct our X-DNA monomers allows the DNA to 
interact with a maleimide group, and a literature search directed me to a chemical 
moiety containing an NTA group linked by three carbons to a maleimide moiety177,178-
179. The structure of this molecule, maleimido-C3-NTA (MC3N), is shown in Figure 
26. 
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Figure 26: Chemical structure of maleimido-C3-NTA (MC3N). The maleimide 
group is included on the right side of the structure while the nickel-chelating 
moiety NTA is on the left. 
 
 MC3N functionalization required the deprotection of the C6-thiol modified 
DNA strand (Figure 47). This deprotection is performed with the reducing agent 
TCEP (tris(2-carboxyethyl)phosphine), which our lab has previously used in 
nanoparticle functionalization with DNA24–28,180. As opposed to DTT, which has also 
been commonly used for such applications, TCEP is non-toxic, does not emit a strong 
or foul odor, and is more stable towards oxidation181,182. TCEP also more specifically 
reduces disulfide bonds than DTT, which acts in a more general manner and is 
commonly removed before further functionalization steps are taken. The original 
protocol thus left TCEP in the reaction as we added the MC3N linker. However, upon 
further review it was noted that TCEP can in fact react with a maleimide group under 
certain conditions183 and was potentially inactivating the MC3N linker. In order to 
ensure the removal of TCEP, we used 10,000 kDa MWCO spin filters from EMD 
Millipore, diluting TCEP concentration in the sample approximately 10,000 times. In 
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conjunction with a 25:1 molar excess of MC3N to DNA, TCEP interference through 
maleimide inactivation was made negligible. 
 The thiol deprotection process was undertaken in 10 mM Tris-NaCl, pH 8.0 
buffer containing no EDTA, as this can interfere with His-tagging later in the 
experimental work. EDTA acts as a metal chelator for divalent ions such as Ni2+, 
potentially stripping the nickel from the NTA groups linked to the DNA. The 
deprotection step is relatively short, with the sample being incubated for one hour at 
room temperature under 600 rpm shaking. The functionalization step was performed 
in TBS at pH 7.6 for 12 hours. An overview of this process is shown in Figure 27. 
  
	  
Figure 27: Overview of the MC3N functionalization procedure. 
	  
Section 4.3 - Testing of functional group presence and functionality 
 
In order to test whether the MC3N was actually linked to the thiol-modified 
DNA, we performed both mass spectroscopy and a functional assay. The mass 
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spectroscopy was performed at the Cornell Core Laboratories Center. The two 
samples, the unmodified and MC3N-modified strand 4 of X-DNA, are shown in 
Figure 28. The mass change of approximately 1400 da corresponds to the combined 
molecular weights of the malemeido-C6-NTA group and the C6-thiol that are added 
onto the DNA. 
 
	  
Figure 28: Mass spectroscopy results for A.) unmodified X-DNA strand 4 B.) 
Maleimido-C3-NTA modified strand 4. 
  
The functional assay used a centrifugal filter with a mass cutoff above that of 
free GFP (~27 kDa) so that only GFP that was interacting strongly with MC3N 
modified X-DNA would be retained in the filter; the molecular cutoff used was 50 
kDa. The modified X-DNA was synthesized using the same hybridization protocol 
shown in Figure 22, with the exception that the previously phosphorylated strand four 
is instead MC3N-functionalized strand four. Figure 29 shows that the MC3N-
functionalized X-DNA forms with high efficiency, with a yield comparable to non-
functionalized X-DNA. Functionalized and non-functionalized X-DNA were 
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incubated with commercial GFP in 1 mM and 10 mM NiCl2 solutions at 25°C for one 
hour, shaking at 600 rpm. Additionally, incubation was performed in lysate 
supplemented with 10 mM NiCl2. 
After incubation, the solutions were washed with Tris-NaCl buffer, centrifuged 
through the columns, and the solution that was left in the filter was measured for 
fluorescence under the plate reader, as shown in Figure 30. One can see that although 
the amount of GFP captured on the gels does increase for both the non-functionalized 
and functionalized sets as nickel concentration increases and in the presence of lysate, 
the MC3N-functionalized X-DNA demonstrates a significantly higher retained yield 
of GFP. 
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Lane 1 ssDNA - Oligo 4 from X-DNA 
Lane 2 X-DNA 
Lane 3 MC3N-Functionalized X-DNA 
 
Figure 29: 2.5% agarose gel showing X-DNA and MC3N-functionalized X-DNA. 
All lanes contain DNAs incubated in Tris-NaCl (10mM). 
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Figure 30: Plate reader values for GFP retained after washing and filtering 
through 50,000 MWCO columns. Values on the y-axis are arbitrary intensity 
units. The concentration of nickel refers to the concentration within the solution 
while incubating with GFP. 
  
  
Section 4.4 - Incorporation of NTA into DNA gel 
 
 The MC3N-X-DNA must be incorporated into P-gel microdroplets without 
significantly affecting the strength of the resulting gel. Functionalization effectively 
removes one linking branch of the X-DNA monomer due to its inability to ligate 
another DNA strand. Thus, not all the X-DNA in the reaction solution can be 
functionalized, as earlier work performed by our lab demonstrated that Y- and T-DNA 
demonstrated a significantly lower tendency to form gel when compared to the X-
DNA due to the lower crosslinking density inherent in the structure46.  
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 With this in mind, we aimed to have the greatest number of NTA groups in the 
gel as possible. Thus, we produced three different DNA gel samples containing 10%, 
20%, or 50% functionalized X-DNA. We were seeking the percentage that could be 
included before the gel network was sufficiently compromised as to induce gel 
breakup upon not only extraction from the emulsions, but under the shaking and 
incubation that would be encountered during cell-free protein synthesis. Only the 10% 
functionalized gels survived both the extraction and shaking conditions. The 20% gels 
did form in the emulsions but did not survive extraction, while the 50% gels did not 
form gels within the emulsions to any visible extent. 
The ability of the functionalized DNA gels to interact with His-tagged GFP 
was then tested. Functionalized and non-functionalized DNA gels were synthesized 
and incubated with 10mM NiCl2 and GFP-His overnight at 30°C under 600 rpm 
shaking. After incubation, the gels were washed with Tris-NaCl by diluting 25X, 
shaking for one hour at 25°C, and then spinning down the gels at 0.2x1000 rcf for five 
min. The supernatant was removed, and the original reaction volume was viewed 
under the fluorescent microscope to observe if any difference was seen between the 
samples. Figure 31 shows the strong GFP signal on the modified gels, which is not 
viewed in the unmodified system.      
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Figure 31: A.) MC3N-functionalized and B.) unmodified P-gel microdroplets 
incubated with GFP and washed to remove non-bound protein. 	  	  
Section 4.5 - DNA bird nest functionalization 	   	  
 As mentioned in Chapter 1, the ligation of branched DNA structures is but one 
method of producing a DNA gel. Another method of gel synthesis performed in our 
laboratory is based on the novel combination of rolling-circle amplification (RCA) and 
multi-primed chained amplification (MCA). This process produces a gel that possesses 
unique metaproperties dependent on whether the gel is in a water or air environment, a 
phenomenon that our lab has studied and shown to be based on specific gravity of the 
surrounding environment184. I was interested in this method of gelation not based on 
these bulk material properties, but rather for another unique outcome of creating a gel 
through this procedure. The bulk gel structure is shown in Figure 32, where high-
density bundles of DNA are linked weakly by small numbers of longer DNA strands. 
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These bundles are referred to as DNA bird nests, and after physical breaking through 
pipetting, the individual bird nests forming the bulk gel are broken apart into discrete 
units. 
 
	  
Figure 32: SEM images of Gel1 before (A) and after (B) mechanical breakup of 
gel linkages to form DNA bird nests. 
 
In considering the mechanism of gel formation, each of these bird nests should 
be formed from one circular template (Figure 33). The elongation of this template 
during RCA provides many primer attachment points during the MCA process, thus 
yielding distinct regions of high DNA density. Each of these discrete bird nests should 
contain hundreds to potentially thousands of copies of the same circular template from 
which it was formed. This provides an extremely high copy number of the template 
covalently linked within a small, discrete gel volume. Such a phenomenon is indeed 
very difficult to replicate with other methods – the only other method capable of 
producing multiple, identical copies from a single template is droplet-based PCR 
amplification185–188. This unique aspect of the bird nests has been explored for its 
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potential in the delivery of large quantities of immunostimulatory CpG sequences to 
cells as well as the delivery of siRNA189. A precise measure of functional copy 
number is very difficult to ascertain as the gel structures contain a mixture of single- 
and double-stranded DNA; it is unclear how many of the template repeats are actual 
functional copies if a double-stranded DNA is required for transcription. Nonetheless, 
it is possible to determine the ‘equivalent copy number’ in each bird nest by 
comparing protein expression yields to solution-phase controls. 
 This platform holds great potential for directed evolution applications, as this 
method provides a cell-free platform for creating localized high-copy numbers of a 
single mutant from a gene library. When typical gene isolation is undertaken in cell-
free expression, notably in in vitro compartmentalization platforms to ensure a 
genotype-phenotype connection, protein is normally produced from one molecule of 
gene template; this naturally leads to very low yields. Gene expression can now be 
performed off of a DNA gel possessing many copies of the same mutant. Combined 
with the ability to functionalize the gel with the same MC3N chemical group used in 
the functionalized P-gel microdroplets to link His-tagged protein, this format offers 
the possibility to address low expression yields present in current cell-free systems 
that in vitro compartmentalization technology while also providing a platform to link 
expressed protein. 
An outline for the synthesis of bulk DNA gel from the RCA/MCA process is 
shown in Figure 33. The MC3N functionalization of primer 2 allows this group to be 
included in the gel as it is being formed. As protein expression and capture is the goal 
of this work, the single-stranded circular template is produced from pIVEX2.3d-GFP. 
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The sequences of the primers used for bird nest formation are listed in Table 11. 
Discrete bird nests are produced from the bulk gel by pipetting the solution, causing 
mechanical breaking of the weak DNA linkages between denser regions of DNA. 
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Figure 33: Synthesis of bird nest DNA gel. The MC3N functionalization is 
performed on Primer 2, and thus is incorporated in the multiprimed chained 
amplification52.  
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 The protein binding functionality of the bird nest gels containing the MC3N 
group was tested using both commercial GFP in buffered solution and in cell-free 
lysate. In buffered solution, both functionalized and non-functionalized gels were 
incubated first in 1 mM NiCl2 for one hour of shaking at 600 rpm, and then introduced 
to commercial GFP. After one hour of incubation at 30°C (the temperature used in 
cell-free protein expression), the gels were washed with 10 mM Tris-NaCl solution 
and viewed under the microscope. Figure 34 shows a significant difference between 
the functionalized and non-functionalized bird nests. Functionalized bird nests possess 
a greater GFP signal than unfunctionalized bird nests. 
 
 
 
 
 
 
 
 
 
 
 
 
Unmodified bird nests washed with 1mM NiCl2 
MC3N-modified bird nests washed with 1mM NiCl2 
Figure 34: (A) MC3N-functionalized and (B) non-functionalized DNA bird nests 
incubated with GFP-6His and washed to remove non-bound GFP. The first, second, 
and third rows are bright field, fluorescent, and an overlay of the two, respectively. 
	   85	  
 
A similar approach was taken to test whether the gels could capture protein in 
cell-free lysate. Gels were incubated with NiCl2, and then were placed in cell-free 
lysate and incubated at 30°C for six hours with commercial GFP-His. Figure 35 shows 
that the modifications made in Section 4.1 to the cell-free lysate does allow for protein 
capture in the bird nest gels. 
In order to test the ‘equivalent copy number’ of the bird nests, protein 
expression levels were measured and are shown in Figure 36. Though it may appear 
that expression levels are negatively affected by use of the bird nests when compared 
to the linear control, if one takes into account the actual number of bird nests 
introduced into the lysate then the expression levels prove to be much more 
impressive. The use of 9,500 bird nests/uL has approximately the same protein yield 
as 15 ng/uL of MluI linearized plasmid. Thus, each bird nest, in terms of its 
contribution to GFP output, represents the equivalent of nearly 500,000 functional 
copies of linear plasmid. In comparison to circular plasmid, this total is closer to 
125,000 functional copies. 
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Figure 35: DNA bird nests after incubation in lysate containing commercial GFP-
His. MC3N-functionalized bird nests are shown in (A) and unmodified bird nests 
are shown in (B). 	  
	  
Figure 36: Comparison of GFP expression levels using bird nest DNA gels.
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Section 4.6 - Increasing thermostability of DNA-based gels 	  
 After ligation into a gel network, complementary strands of the X-DNA 
network are held together through hybridization, and thus the gel is subject to the same 
temperature and salt variations as double-stranded DNA. In low salt conditions, the X-
DNA can actually dehybridize into the four individual strands, as shown in Figure 43. 
The ligation of X-DNA into a network gel structure covalently links X-DNA 
monomers together, but still contains a double-stranded scaffold that is held together 
through hybridization. Due to the central crossover junction necessary to construct the 
X-DNA, the longest uninterrupted double-stranded binding created through ligation is 
40 bases, regardless of how many X-DNAs are covalently linked. The melting 
temperature of these strand sequences is approximately 65°C, as seen in Figure 37. At 
this temperature, 50% of the sequences become dehybridized. As the temperature of 
the gel environment approaches and exceeds this temperature, the gel begins to fall 
apart.  In order to interface with cell-free processes and proteins under extreme 
conditions of low salt, high temperature, and extreme pH, it is necessary to chemically 
stabilize the DNA gel.  Interest in studying proteins in extreme environments has been 
growing as scientists have discovered and begun studying novel classes of organisms 
termed ‘extremophiles’ that thrive under conditions not tolerated by the majority of 
living systems.  Such enzymatic systems offer the ability to conduct biological 
engineering under industrial conditions that would normally be destructive to more 
commonly encountered proteins190,191. 
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Figure 37: Depiction of longest continuous hybridized strands in ligated X-DNA 
structures. 
 
One may consider that since X-DNAs are ligated together in the P-gel, the 
oligos should form continuous, covalently linked strands that span the whole gel; thus, 
the gel may be expected to expand at higher temperatures but not necessarily fall 
apart. However, this assumption would be based on 100% ligation efficiency, which 
the system certainly does not reach. This value has not been intensively studied, but as 
the ligation is accomplished through an enzymatic reaction the efficiency is assumed 
to be less than 100%. This efficiency is further compromised as gelation occurs and 
retards the diffusion of enzymes and molecules through the gel. Though multiple X-
DNAs may be ligated and form long, covalently linked strands spanning multiple X-
DNA structures, a non-ligated point will eventually be reached within the gel. Above 
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the melting temperature of the ligated arm-spans, single stranded DNA can detach 
from the scaffold and, in effect, dissociate and ‘leave’ the droplet. 
In addition to a lack of mechanical robustness at elevated temperatures, 
double-stranded DNA possesses a natural tendency to ‘breathe’, or display local 
denaturation and reclosing of the double strand192–194. This breathing process can 
potentially reduce the strength of the gel. This breathing tendency is elevated by the 
use of a crossover junction in the X-DNA structure195, meaning that each node is 
potentially vulnerable to stresses on the gel structure. These stresses can come from 
multiple sources, including changes in temperature, pH, or mechanical stress induced 
through processes such as droplet purification and shaking during incubation. 
In order to strengthen the structure of the gels without fundamentally changing 
the method of gelation and incorporation of gene, we developed a method to 
covalently link the double helix between complementary strands making up each X-
DNA. Psoralen, a naturally occurring molecule that has been shown to specifically 
intercalate and crosslink DNA in the presence of ultraviolet light51,196–198, was 
introduced to the X-DNA before ligation to produce covalently bonded X-DNAs. The 
introduction before ligation is necessary due to the end goal of this gel formation – 
gene expression. If psoralen is introduced after gene ligation into the gel network, the 
opposing strands of the gene itself will be crosslinked and thus rendered unusable for 
protein expression applications. 
Psoralen is a molecule that displays an affinity to intercalate DNA at specific 
base pair combinations199–202. The 5’ – TA – 3’ sequence possesses the strongest 
tendency for psoralen intercalation, followed by 5’ – AT – 3’. Other base 
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combinations show a low tendency for psoralen intercalation. Consideration of these 
intercalation properties of psoralen was, of course, not within the original design 
considerations of the X-DNA sequences. Thus, in analyzing the original X-DNA oligo 
sequences for the presence of 5’ –TA – 3’ as representative psoralen binding sites, 
three arms contain two bindings sites and one arm contains one. Furthermore, these 
binding sites are at different locations on the arms, which can introduce heterogeneity 
to what should be a symmetrical structure. 
In order to gain greater control over psoralen intercalation, we altered the 
sequence of the X-DNA oligos to meet certain predetermined conditions. These 
conditions required that the same number of crosslinking sites be present on each arm, 
in the same location, and not in proximity to the sticky ends. The last condition is due 
to the fact that psoralen intercalation causes a deformity in the helical structure of the 
DNA and thus can interfere with ligation196. Figure 38 demonstrates that Y-DNA is 
able to ligate efficiently before psoralen treatment, but this efficiency is significantly 
reduced after psoralen crosslinking. Considering the original X-DNA sequences 
contained 5’ – TA – 3’ sites within five bases of the arms’ sticky end overhangs, 
ligation efficiency would be significantly reduced had this sequence not been 
modified. 
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Lane 1 Untreated Y-DNA with red fluorophores 
Lane 2 Untreated Y-DNA with green fluorophores 
Lane 3 Untreated Y-DNA mixed together without ligase 
Lane 4 Untreated Y-DNA mixed together with ligase 
Lane 5 Crosslinked Y-DNA with red fluorophores 
Lane 6 Crosslinked Y-DNA with green fluorophores 
Lane 7 Crosslinked Y-DNA mixed together without ligase 
Lane 8 Crosslinked Y-DNA mixed together with ligase 
 
Figure 38: Effect of psoralen crosslinking on ligation efficiency. Note the yellow 
band in lane 4 is created by the ligation of two Y-DNAs containing either green 
or red fluorophores. The same amount of psoralen-crosslinked Y-DNA yields a 
significantly lower intensity yellow band, as seen in lane 8. 
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The four X-DNA oligo sequences were redesigned to have the same guanine 
and cytosine makeup as the original oligos as well as similar thermodynamic 
properties. So while the sequences were modified to incorporate the desired changes 
and introduce isotropicity to the psoralen crosslinking, the ability to form X-DNA 
should not be significantly affected. The specifics of this redesign are in Table 7. 
 
Table 7: Considerations for sequence redesign of X-DNA to enable symmetrical 
psoralen intercalation and higher ligation efficiency after psoralen crosslinking39. 
Redesign of Thermostable X-DNA 
The inclusion of one 5’ – TA – 3’ site at a distance of 2 bp away from the junction 
The removal of all other 5’ – TA – 3’ as well as 5’ – AT – 3’ pairings 
Sequence swapping to retain the same GC percentage in each of the arms as well as 
similar thermodynamic characteristics 
 
 
The redesigned sequences are shown in Figure 39 and Table 12. One can see in 
Table 8 that this redesign was achieved while maintaining the thermodynamic 
characteristics of the original X-DNA sequences, which were selected based on design 
considerations discussed in our lab’s previous dendrimer-DNA work39. Comparison of 
the X-DNA annealing yields are shown in Figure 40, and it is seen that they anneal in 
the same yields as the original X-DNA sequences. 
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Figure 39: Redesigned X-DNA for greater control over psoralen intercalation. 
Bases highlighted in red depict a directed crosslinking site, while sequences in 
blue represent the ApaI restriction site overhang. 	   	  
Table 8: Comparison of free energy of hybridization between sequences in the 
original X-DNA strands and redesigned X-DNA strands.	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Lane 1 NEB LMW Ladder 
Lane 2 Original X-DNA 
Lane 3 Original X-DNA 
Lane 4 Redesigned X-DNA 
Lane 5 Redesigned X-DNA 
Lane 6 Oligo 4 from X-DNA 
 
Figure 40: Testing the ability of redesigned X-oligos to form branched X-DNA. 
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The formation of psoralen diadducts that covalently link complementary DNA 
strand requires UV exposure, but the process of UV-crosslinking hybridized X-DNA 
can be damaging to the DNA203. This DNA damage, in turn, can negatively affect 
ligation efficiency, thus negating any mechanical benefits of the psoralen crosslinking. 
This means that it is not only necessary to change the number and location of the 
directed crosslinking sites, but to optimize the reaction conditions to induce the least 
possible damage to the DNA. 
Whereas our lab’s earlier work utilized a significant excess of psoralen (1000:1 
psoralen:X-DNA excess) and a long UV exposure time (15 minutes), the DNA 
structures were acting as primers in a PCR reaction rather than branched units in a 
ligated network. Nucleotide damage to the ends of the DNA serving as a PCR primer 
may not make a significant difference in PCR efficiency, as the primer will still 
hybridize using the majority of the bases (15-20) even if multiple bases have been 
damaged. In using a double-stranded DNA-strand for ligation, the damaging of the 
terminal base yields an overhang that cannot be ligated. Thus, care must be taken to 
produce psoralen-crosslinked X-DNA that has not been compromised as to its ligation 
efficiency. To this end, it is necessary to minimize both the concentration of psoralen 
and UV exposure time. Psoralen was dissolved in DMF, an organic solvent which can 
be damaging to DNA if left in the solution, while UV exposure can lead to direct 
damage of the DNA through breaking of bonds as well as the production of free 
radicals which in turn can lead to DNA instability203.  
Initial experiments to test lower psoralen concentrations were performed at 
either 800:1 or 80:1 molar ratios of psoralen: X-DNA. Figure 41 shows that the lower 
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concentration actually does result in less efficient crosslinking. However, the need for 
every potential intercalation site to be crosslinked is not necessary. In reality, very few 
sites would need to be crosslinked in order to have a potentially significant effect on 
thermostability in a ligated X-DNA system. As stated previously, the ligated oligos 
form long single strands, and one psoralen-crosslinked site on that strand should be 
sufficient to keep the strand from escaping the gel under high temperature conditions 
above the melting temperature of ≈65°C. Experiments were thus performed with 5:1, 
50:1, and 100:1 molar excess of psoralen:X-DNA. This yields a 1.25:1, 12.5, and 25 
molar excess of psoralen to directed crosslinking sites, as each X-DNA contains four 
5’ – TA – 3’ sequences. These particular excesses were selected as they represent 1X, 
10X, and 20X molar ratios per intercalation site with an additional proportional excess 
to account for off-target crosslinking and molecular degradation.	  
In addition to changing the reaction stoichiometry, we also modified the 
reactions times to determine whether the benefits of UV exposure (potentially higher 
yield of psoralen-crosslinked DNA) was outweighed by damage to the DNA. Figure 
42 shows that reactions times 15 minutes and greater yield no difference in the amount 
of crosslinking occurring, and thus longer exposure times only serve to further damage 
the DNA. Exposure times were shortened based on this result to one minute and five 
minutes. Bulk DNA formation was used to provide an initial idea of whether the 
reactions were causing any physical change in the gel resulting from ligation of 
psoralen-crosslinked X-DNA. Based on Figure 17, which shows the results of gel 
using a one minute exposure time and a 5:1 psoralen:X-DNA ratio, we selected this 
condition; the resulting gel was more distinct and robust than other non psoralen-
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crosslinked gels. In addition, when incubated under pure aqueous conditions (no salt) 
that would normally cause X-DNA to dehybridize into its constitutive four strands, the 
5:1 psoralen-crosslinked X-DNA showed significantly less dehybridization (Figure 
43). Pure water causes the dissociation of X-DNA due to a lack of charge screening, as 
DNA is negatively charged and requires salts to stabilize the helix and allow for 
hydrogen bonding between bases. 
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  Lane	  1	   YTS	  (1000:1	  psoralen:X-­‐DNA)	  Lane	  2	   XTS	  (20:1	  psoralen:X-­‐DNA)	  Lane	  3	   XTS	  (20:1	  psoralen:X-­‐DNA)	  Lane	  4	   XTS	  (1000:1	  psoralen:X-­‐DNA)	  Lane	  5	   LMW-­‐Plus	  Ladder	  (NEB)	  	  
Figure 41: X-DNA and psoralen-crosslinked X-DNA (XTS) stability in SDS-
PAGE gel based on high and low ratios of psoralen: X-DNA in the crosslinking 
solution. 
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 Lane	  1	   LMW-­‐Plus	  Ladder	  (NEB)	  Lane	  2	   XTS	  Lane	  3	   YTS	  Lane	  4	   X	  Lane	  5	   XTS	  (15	  min)	  Lane	  6	   XTS	  (30	  min)	  Lane	  7	   XTS	  (45	  min)	  Lane	  8	   XTS	  (60min)	  Lane	  9	   XTS	  (90	  min)	  
 
Figure 42: SDS-PAGE gel comparing different UV exposure times for psoralen 
crosslinking (15-90 min exposures of 2.5 mWcm-2 UV light at 365 nm).  There is 
no significant difference between crosslinked X-DNA (XTS) at the exposure times 
used. 
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 Lane	  1	   ssDNA - Oligo 4 from X-DNA	  Lane	  2	   X-­‐DNA	  (Tris-­‐NaCl	  incubation)	  Lane	  3	   5:1	  psoralen	  crosslinked	  X-­‐DNA	  (Tris-­‐NaCl	  incubation)	  Lane	  4	   X-­‐DNA	  (H2O	  incubation)	  Lane	  5	   5:1	  psoralen	  crosslinked	  X-­‐DNA	  (H2O	  incubation)	  	  
Figure 43: 2.5% agarose gel comparing the dehybridization of X-DNA and 
psoralen-crosslinked X-DNA in nuclease-free water. 
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In order to test the whether the psoralen crosslinking procedure instituted 
above actually made a difference in the thermal stability properties of microgels, we 
produced a set of gels under the same ligation conditions as a non psoralen-crosslinked 
system. Briefly, we used a final concentration of 125 µm psoralen-crosslinked DNA 
and ligated at 16°C for 24 hours before collecting the microgels from emulsions. Both 
microgel sets were placed in the spectrophotometer, and the gels were allowed to 
settle at the bottom of the cuvettes before a temperature ramp to 95°C at 0.1°C/min. 
As seen in Figure 44, the different gels possess very different melting curve profiles. 
Absorbance levels in both solutions increase from approximately 25°C to 50°C, which 
we attribute to the release of non-ligated X-DNA from the gels (these may still be held 
in the gels through hybridization, which is disrupted even at these lower 
temperatures). At approximately 65°C, which is the melting temperature of the longest 
continuous stretch of DNA in the gel network, the non-crosslinked gels appear to 
begin rapidly falling apart, whereas the crosslinked gels appear to maintain the X-
DNA in a gel format. 
 After the temperature of the cuvettes returned to room temperature, we looked 
at the samples under the microscope to view whether there were in fact any microgel 
structures left in either sample. Figure 45 reveals that the crosslinked microgels gels 
did, in fact, remain in the sample while the control gels were not present. Thus, 
psoralen crosslinking did appear to significantly improve the thermostability of the 
microgels.
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Figure 44: Melting curve for P-gel and thermostable P-gel microdroplets. 
Droplets were allowed to settle at bottom of cuvette before s temperature ramp at 
0.1°C/min. 
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Figure 45: Demonstration of thermostability in psoralen-crosslinked microgels. 
The images labeled 95°C degree were taken after the solutions had cooled back 
down to 25°C. 	  	   Lastly,	   it	  was	   tested	  whether	  psoralen	  crosslinking	   influenced	   the	  ability	  of	   the	  P-­‐gel	  microgels	   to	   engage	   in	   cell-­‐free	  protein	   synthesis.	   The	   crosslinking	  does	   not	   affect	   the	   gene	   itself,	   as	   the	   gene	   is	   introduced	   after	   psoralen	  crosslinking,	   but	   may	   affect	   enzymes	   that	   recognize	   and	   bind	   DNA.	   Enzymes,	  such	   as	   polymerase,	   may	   use	   the	   DNA	   network	   as	   a	   scaffold,	   and	   thus	  interference	   with	   the	   natural	   DNA	   form	   may	   impede	   this	   process.	   Figure 46	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demonstrates	   that	   while	   expression	   is	   significantly	   affected,	   the	   psoralen-­‐crosslinked	   P-­‐gel	   microdroplets	   still	   serve	   as	   a	   functional	   protein-­‐producing	  platform.	  	  
	  
Figure 46: Cell-free protein expression of pIVEX2.3d-GFP using psoralen-
crosslinked (CL-P-gel) and non-crosslinked P-gel microdroplets. 	  	  
Section 4.7 – Summary 	  	   The	  use	  of	  DNA	  as	  the	  platform	  for	  hydrogel	  formation	  opens	  up	  different	  pathways	   of	   functionalization	   to	   expand	   the	   use	   and	   application	   of	   DNA	  microgels	   in	   cell-­‐free	   protein	   synthesis.	   Here,	   we	   present	   methods	   to	   capture	  proteins	  on	  microgels,	  increase	  gene	  copy	  number	  in	  discrete	  gels,	  and	  enable	  gel	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use	   under	   extreme	   conditions	   such	   as	   high	   pH	   and	   high	   temperature.	  Incorporation	   of	   the	   chemical	   group	   maleimido-­‐C3-­‐NTA	   allowed	   for	   effective	  binding	   of	   His-­‐tagged	   proteins,	   which	   can	   be	   added	   to	   the	   gene	   sequence	  incorporated	   into	   the	   gel	   matrix.	   This	   same	   functional	   group	   was	   also	  incorporated	   in	   DNA	   bird	   nests,	   which	   consist	   of	   a	   different	   DNA	   microgel	  structure	   than	   the	   P-­‐gel	   discussed	   in	   previous	   sections.	   These	   gels	   are	  significantly	  smaller	  and	  naturally	  are	  formed	  from	  one	  gene	  template,	  producing	  potentially	  thousands	  of	  copies	  of	  each	  gene	  within	  a	  discrete	  gel	  and	  expressing	  protein	  in	   levels	  equivalent	  to	  approximately	  500,000	  linear	  plasmid	  copies	  per	  bird	   nest.	   Lastly,	   the	   P-­‐gel	   format	   is	   amenable	   to	   psoralen	   crosslinking	   of	   its	  double-­‐stranded	   structure.	   	   This	   process	   enables	   gel	   survival	   at	   high	  temperatures	  while	  still	  allowing	  for	  gene	  expression.	  Although	   the	   feasibility	   of	   these	   methods	   has	   been	   demonstrated	   here,	  future	   developments	   will	   have	   to	   focus	   on	   optimizing	   protein	   capture	   of	   the	  proteins	  produced	  from	  the	  gene	  sets	  contained	  within	  P-­‐gels	  and	  bird	  nests	  and	  testing	  the	  validity	  of	  the	  genotype-­‐phenotype	  connection.	  In	  order	  to	  tackle	  this	  task,	  a	  different	  red	  fluorescent	  reporter	  must	  be	  selected	  or	  optimization	  of	  gene	  concentration	   within	   the	   P-­‐gel	   must	   be	   undertaken	   to	   ensure	   this	   protein	   is	  produced	   in	   assayable	   concentrations.	   This	   is	   further	   evidence	   that	   different	  genes	  can	  have	  varied	   responses	   to	   cell-­‐free	   reaction	  conditions.	  The	  benefit	  of	  DNA-­‐based	   hydrogels	   as	   the	   material	   interface	   means	   that	   conditions	   can	   be	  tuned	  to	  optimize	  expression	  of	  the	  gene-­‐of-­‐interest.	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Section 4.8 - Materials and methods 	  
Cell Lysate 
The production of cell-free lysate was based on the production of an S12 
lysate, which is faster and cheaper to produce while producing similar yields as the 
commonly used S30 lysate166–168. Briefly, BL21 (DE3) E.coli is grown in enriched 
media, and synthesis of T7 polymerase under the lacU5 promoter is induced by 
introduction of IPTG. The cells are centrifuged, pelleted, and resuspended in buffer. 
The internal cell components are extracted by use of a French press and further 
centrifugation to remove cell debris and the large amount of lipid from the 
membranes. 
 This BL21 lysate is supplemented with further components necessary for 
energy production, specifically creatine phosphate, as well as additional monomers for 
RNA and protein production. The complete reaction mixture is shown in Table 9, with 
PEG and spermidine recipes included. DTT concentration was also modified as 
discussed in Section 4.2. 
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Table 9: Components included in the cell-free protein expression reaction 
mixture. 
Component Standard 
Reaction 
Spermidine 
Reaction 
 
Final 
Concentration 
1 M Hepes-KOH 
Buffer (pH 8.2) 
5.7 µl 5.7 µl 57 mM 
50 mM ATP 2.4 µl 2.4 µl 1.2 mM 
50 mM CTP 1.7 µl 1.7 µl 0.85 mM 
50 mM GTP  1.7 µl  1.7 µl 0.85 mM 
50 mM UTP 1.7 µl 1.7 µl 0.85 mM 
500 mM DTT 0.4 µl 0.4 µl 2 mM 
10 mg/ml E. coli total 
tRNA mixture  
(from strain MRE600) 
1.7 µl 1.7 µl 0.17 mg/ml 
 15 mM cAMP 4.27 µl 4.27 µl 0.64 mM 
 2M Potassium 
Glutamate 
4.5 µl 4.5 µl 90 mM 
 2 M Ammonium 
Acetate 
4 µl 4 µl 80 mM 
1 M Magnesium 
Acetate 
1.2 µl 1.2 µl 12 mM 
1 mg/ml Folinic Acid  
(L-5-formyl-5,6,7,8-
tetrahydrofolic acid) 
3.4 µl 3.4 µl 34 µg/ml 
Each of 20 Amino 
Acids 
17.98 µl 17.98 µl 1.5 mM/AA 
20% PEG (8000) 10 µl N/A 2% 
1 M Creatine Phosphate 
(CP) 
6.7 µl 6.7 µl 67 mM 
 500 µg/ml Creatine 
Kinase (CK) 
0.64 µl 0.64 µl 3.2 µg/ml 
pIVEX 2.3d-Gene of 
Interest (500 µg/ml)  
1.34 µl 1.34 µl 6.7 µg/ml 
S12 E. coli Lysate  
– 2x YT 
27 µl 27 µl 27% (v/v) 
100 mM M Spermidine N/A 1.5 µl 1.5 mM 
Nuclease-Free Water 3.67 µl 12.17 µl To 100 µl 
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Maleimido-C3-NTA Functionalization of DNA 
Maleimido-C3-NTA was ordered from Dojindo Industries (Japan). We brought 
the stock to 20 mM in TBS solution and left in 4°C in dark conditions for long-term 
storage, as MC3N is light sensitive. 
Strand four of the X-DNA sequence was ordered with 5’ Thiol Modifier C6 S-
S from Integrated DNA Technologies (IDT®). The DNA was deprotected by addition 
of 100:1 molar TCEP excess in a 100 µM solution of DNA, and incubated and shaken 
for one hour at 25°C and 600 rpm. The TCEP was removed using a 10 kDa MWCO 
filter column from EMD Millipore, and the DNA was eluted in TBS buffer. MC3N 
was immediately added in 25:1 molar excess, and incubated and shaken for 12 hours 
at 16°C and 600 rpm under dark conditions. MC3N was removed using a 10 kDa 
MWCO filter column and incorporated into X-DNA through the hybridization 
protocol discussed in Section 3.5. 
 
 
	  	  	  	  	  	  	  	  	   	  
Figure 47: The functional group 5’ Thiol Modifier C6 S-S as provided by IDT on 
the ordered oligo. 	  
	   109	  
Mass Spectrometry 
Data was acquired by an AB/Sciex (Foster City, CA USA) 4000 Q Trap 
outfitted with the Turbo Ion Spray source. The instrument was operated in negative 
ion, enhanced (EMS) mode scanning at 4000 amu/sec from m/z 400-1800Da. The 
samples were diluted to 250ul in 50% acetonitrile/water and infused directly into the 
ion source at 5 µl/minute. The Total Ion Chromatogram (TIC) was acquired using 
MCA (Multiple Chromatogram Addition) until the base peak signal reached at least 
8.0e6 counts/sec. Further parameters for operation are shown in Table 10. Three 
adjacent, highest abundance ions in the charge envelope were selected and 
deconvoluted using Analyst 1.4.2 software (AB/Sciex) to obtain the molecular weight 
of the dominant species.  
 
Table 10: Operating conditions for mass spectrometer. 
Curtain Gas (CUR) 30.0 (arbitrary units) 
Ion Spray Voltage (IS) -4200V 
Collision Gas (CAD) Low 
Interface Temperature (TEM) 200°C 
Gas 1 (GS1) 15.0 (arbitrary units) 
Gas 2 (GS2) 20.0 (arbitrary units) 
Declustering Potential (DP) -150V 
Collision Energy (CE) -5.0V 
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SEM Imagery 	  
SEM images were obtained using the LEO 1550 FESEM at a 2.0 kV setting. 
Samples were freeze-dried on silicon wafer and held under vacuum until imaging. 
 
Table 11: Primers used for DNA bird nest synthesis with pIVEX2.3d-GFP as the 
template. Primer 1 is used during RCA, and primers 2 and 3 are used during 
MCA. Primer 2 is thiolated to allow for further functionalization with MC3N. 
Strand Modification Sequence (5’ – 3’) 
Primer 1 None CCAGCGTTTCTGGGTGAGCAAAAACAGGAA 
Primer 2 5’-Thiol TATTACCGCCTTTGAGTGAGCTGATACCGC 
Primer 3 None GCGGTGTGAAATACCGCACAGATGCGTAAG 	  
Table 12: Sequences for the original X-DNA and redesigned X-DNA for psoralen 
crosslinking. All sequences listed here contain a 3’ ApaI overhang sequence. 
Strand	   Original	  X	  sequence	  (5’	  to	  3’),	  5’-­‐phoshorylated	  
1	   CGACCGATGAATGACGGTCAGATCCGTACCTACTCGGGC	  
2	   CGAGTGGTACGGATCTGCCGTATTGCGAACGACTCGGGCC	  
3	   CGAGTCGTTCGCAATACGGCTAGTCGTGATGTCTCGGGCC	  
4	   CGAGACATCACGACTAGCACCGTCATTATCGGTCGGGCC	  
Strand	   Redesigned	  X	  sequence	  (5’	  to	  3’),	  5’-­‐phoshorylated	  
1	   CGACTCGAGAAGACTAGTCGTACGCTGACTCACTCGGGCC	  
2	   CGAGTGAGTCAGCGTACGAGTACTTCGAACGACTCGGGCC	  
3	   CGAGTCGTTCGAAGTACTGCTAGTCGTGCTGTCTCGGGCC	  
4	   CGAGTCGTTCGAAGTAGCACTAGTCTTCTCGAGTCGGGCC	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CHAPTER 5: CONCLUSION AND FUTURE PERSPECTIVE 	  	   One	  of	  the	  fundamental	  challenges	  in	  bioengineering	  is	  the	  consideration	  of	   how	   materials	   interface	   with	   biological	   systems.	   When	   the	   materials	  themselves	  are	  constructed	  out	  of	  biological	  molecules,	  the	  ability	  to	  control	  the	  type	   and	   degree	   of	   interaction	   is	   greatly	   enhanced.	   DNA	  materials	   engineering	  provides	   a	   path	   towards	   designing	   and	   synthesizing	   materials	   that	   not	   only	  specifically	   interact	   with	   other	   DNA	   and	   RNA,	   but	   with	   an	   enormous	   range	   of	  enzymes	  and	  cell	  processes.	  Though	  the	  ‘generic’	  properties	  of	  DNA	  are	  touted	  –	  such	  as	  the	  precise	  control	  over	  length,	  monodispersity	  –	  the	  real	  benefits	  of	  DNA	  as	  a	  material	  emerge	  precisely	  because	  of	  the	  genetic	  nature	  of	  the	  polymer.	  The	  ability	   to	   precisely	   control	   the	   interactions	   between	   single	   strands	   of	  DNA	   and	  RNA	   allows	   an	   unmatched	   ability	   to	   form	  different	   structures	   at	   the	   nanoscale	  beyond	  the	  common	  double-­‐stranded	  format.	  These	  more	  complex	  structures	  can	  be	  engineered	   to	   form	   larger,	  networked	  materials	  at	   the	  microscale,	  providing	  opportunities	  for	  incorporation	  of	  different	  DNA	  and	  RNA	  structures	  or	  targets	  as	  well	  as	  further	  functionalization.	  	   The	  synthesis	  of	  X-­‐DNA	  as	  a	  crosslinkable	  monomer	  for	  gel	  synthesis,	  and	  the	   process	   as	   described	   in	   this	   work	   to	   optimize	   and	   modify	   the	   system,	  demonstrates	   the	   potential	   and	   versatility	   of	   DNA	   nanotechnology.	   Sticky	   end	  sequences	  were	   changed	   not	   only	   to	   accommodate	   plasmids	   cut	  with	   different	  restriction	   enzymes,	   but	   also	   to	   improve	   the	   robustness	   of	   the	   microgels.	   The	  flexibility	  to	  make	  targeted	  changes	  in	  the	  sequence	  of	  the	  plasmid	  itself	  allowed	  
	   112	  
us	  to	  optimize	  expression	  of	  linear	  plasmids	  and	  still	  interface	  these	  plasmid	  with	  the	  X-­‐DNA	  showing	  the	  best	  gel	  characteristics.	  The	  benefits	  to	  the	  optimization	  of	  linear	  gene	  expression	  are	  important	  for	  cell-­‐free	  expression,	  but	  this	  issue	  is	  also	   alleviated	   when	   the	   gene	   itself	   is	   ligated	   into	   the	   DNA	   gel	   network.	   The	  significant	   decrease	   in	   protein	   yield	   from	   linearized	   plasmids	   as	   opposed	   to	  circular	  plasmids	  (approximately	  a	  5x	  decrease	  in	  yield)	  most	  likely	  stems	  from	  elevated	  nuclease	  degradation	  of	  the	  linear	  template.	  The	  results	  showed	  that	  the	  further	  the	  cutting	  site	  was	  from	  the	  gene	  of	  interest,	  the	  higher	  the	  protein	  yield.	  The	  P-­‐gel	  has	  been	  shown	   to	  protect	  DNA	   from	  nuclease	  degradation,	  and	   thus	  would	  aid	   in	  this	  regard.	   In	  cases	  where	  either	  a	  PCR	  gene	  construct	   is	  used,	  or	  only	  small	  DNA	  sequences	   flank	  the	  ends	  of	  a	  gene	  within	  a	   linearized	  plasmid,	  gene	  incorporation	  into	  P-­‐gel	  can	  provide	  a	  significant	  increase	  in	  protein	  yield.	  	   Though	  protein	  yields	  were	  not	  greatly	  increased	  as	  in	  our	  original	  work	  using	  P-­‐gel,	  one	  must	  keep	  in	  mind	  the	  important	  difference	  in	  the	  lysate	  systems	  used.	  Whereas	  that	  work	  used	  wheat	  germ	  lysate,	  a	  eukaryotic	  lysate,	  the	  use	  of	  
E.	  coli	  lysate	  was	  more	  apt	  in	  this	  case.	  The	  large	  number	  of	  reactions	  needed	  and	  the	   changing	   of	   the	   lysate	   itself	   to	   accommodate	   the	   functionalization	   required	  for	  protein	  capture	  made	  E.	  coli	  lysate	  a	  better	  choice	  for	  testing.	  Eukaryotic	  and	  prokaryotic	  systems	  differ	  in	  enzyme	  makeup	  and	  functionality,	  and	  thus	  where	  the	  DNA	  gel	  may	  have	  provided	  an	  ideal	  scaffold	  for	  eukaryotic	  transcription	  and	  translation,	   it	   appears	   to	   have	   less	   of	   an	   effect	   in	   the	   prokaryotic	   system.	  Regardless	  of	  the	  specific	  increase	  in	  protein	  yields,	  the	  initial	  bulk	  gel	  format	  has	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been	  modified	  into	  a	  controllable	  and	  scalable	  microgel	  platform	  that	  successfully	  produces	  protein	  from	  incorporated	  gene	  sets.	  	   The	   functionalization	   of	   DNA	   microgels	   in	   this	   thesis	   offers	   a	   proof-­‐of-­‐concept	   platform	   for	   expanding	   the	   use	   of	   DNA	   materials	   in	   cell-­‐free	   protein	  expression	  applications.	  A	  critical	   issue	  surrounding	  cell-­‐free	  directed	  evolution	  systems	   is	   the	   isolation	   of	   gene	   sets	   and	   the	   maintenance	   of	   a	   genotype-­‐phenotype	   connection.	   The	   microfluidic	   synthesis	   of	   microgels	   provides	   a	  platform	  for	  the	  isolation	  of	  a	  mutant	  gene	  library,	  with	  genes	  being	  incorporated	  into	  ligated	  DNA	  network	  surrounded	  by	  a	  large,	  shared	  solution	  volume	  without	  utilizing	  the	  confines	  of	  an	  emulsion.	  Protein	   capture	   to	   maintain	   a	   representative	   genotype-­‐phenotype	  connection	   of	   a	   microgel’s	   gene	   and	   associated	   protein	   set	   is	   a	   complex	   task.	  Although	  further	  work	  is	  needed	  to	  optimize	  protein	  capture	  functionality	  of	  the	  gels	  and	  to	  show	  that	  captured	  proteins	  are	  indeed	  produced	  from	  the	  associated	  gene	   set,	   the	   work	   presented	   here	   represents	   a	   first	   step	   in	   marrying	   the	  concepts	  of	  protein	  expression	  and	  capture	  with	  DNA	  materials.	  Protein	  capture	  onto	   DNA	   scaffolds	   has	   been	   achieved	   previously,	   but	   most	   often	   on	   origami	  platforms	  and	  not	  in	  a	  high-­‐throughput	  material	  system.	  	  	   Though	   I	   did	   not	   discuss	   in	   detail	   the	   methods	   behind	   DNA	   bird	   nest	  synthesis	   as	   this	  was	   not	   the	   focus	   of	  my	  work,	   the	   refocusing	   of	   this	   process	  using	   plasmid	   as	   the	   material	   template	   offers	   great	   potential	   for	   directed	  evolution	  applications.	  In	  regard	  to	  gene	  isolation,	  each	  bird	  nest	  is	  formed	  from	  a	  single	  gene	  template	  and	  thus	  the	  mechanism	  of	  formation	  itself	  ensures	  library	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separation.	   The	   gelation	   process	   provides	   the	   only	   method,	   outside	   emulsion	  PCR,	   that	  will	   amplify	  a	  gene	  and	  keep	   the	  copies	  of	   that	  gene	  within	   the	   same	  physical	   volume.	   Furthermore,	   the	   physical	   linking	   of	   the	   gene	   copies	   in	   bird	  nests	   makes	   this	   material	   more	   convenient	   to	   interface	   with	   other	   processes	  when	  compared	  to	  gene	  copies	  in	  emulsions.	  As	  shown	  in	  this	  thesis	  work,	  cell-­‐free	   protein	   expression	   per	   bird	   nest	   is	   extremely	   high.	   Protein	   capture	   did	  function	  on	  this	  material,	  but	  again,	  further	  work	  is	  needed	  to	  determine	  whether	  each	   gel	   is	   capturing	   mainly	   proteins	   from	   its	   own	   gene	   makeup	   or	   simply	   a	  sampling	   of	   the	   larger	   solution	   volume.	   Bird	   nests	   using	   other	   fluorescent	  reporter	   proteins	   should	   be	   synthesized	   and	   tested	   to	   confirm	   this	   genotype-­‐phenotype	  connection.	  However,	  even	  should	  this	  not	  be	  case,	  the	  DNA	  bird	  nest	  format	   can	   interface	   with	   existing	   emulsion	   formats	   to	   provide	   an	   unmatched	  method	   of	   increasing	   the	   copy	   number	   of	   gene	   mutants	   during	   protein	  expression.	  Current	  gene	  library	  isolation	  and	  emulsion	  expression	  processes	  use	  infinite	   dilutions	   to	   express	   protein	   from	   one	   gene	   molecule;	   the	   method	  presented	  here	  provides	  a	  straightforward	  path	  to	  increasing	  protein	  yield	  in	  an	  emulsion-­‐based	  system.	  	   Lastly,	   I	   explored	   the	   concept	  of	   thermostable	   gels	  within	   the	   context	  of	  cell-­‐free	  protein	  expression	  and	  directed	  evolution.	  Interest	  in	  proteins	  that	  act	  in	  a	   variety	   of	   different	   environments,	   under	   potentially	   extreme	   temperature	  and/or	  pH	  conditions,	  is	  growing	  as	  extremophiles	  have	  been	  shown	  to	  not	  only	  survive,	   but	   thrive,	   in	   such	   conditions.	   In	   areas	   such	   as	   biofuels,	   proteins	   that	  maintain	   enzymatic	   activity	   under	   high	   temperatures	   can	   more	   efficiently	   act	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under	   conditions	   that	   aid	   in	   cellulose	   degradation.	   Tailoring	   proteins	   to	   better	  suit	   industrial	   processes	   can	   be	   performed	   in	   cell-­‐free	   systems,	   but	   materials	  used	  in	  these	  systems	  also	  need	  to	  be	  able	  to	  withstand	  the	  selection	  pressures.	  By	  utilizing	   the	   great	   sequence	   flexibility	   of	  DNA,	   I	  was	   able	   to	   redesign	   the	  X-­‐DNA	  structures	  previously	  used	  in	  the	  lab	  to	  accommodate	  a	  spatially	  controlled	  covalent	  crosslinking	  of	  the	  double	  helix.	  It	  is	  interesting	  that	  although	  effectively	  the	   same	   monomer	   is	   being	   used	   for	   creating	   the	   gel	   network,	   the	   covalent	  linking	  near	  the	  X-­‐DNA	  junction	  significantly	  increases	  the	  thermostability	  of	  the	  resulting	  gels.	  	   The	  achievements	  presented	  here	  open	  up	  avenues	  for	  further	  work	  in	  the	  research	  space	  of	  protein	  engineering.	  The	  in	  vitro	  DNA	  microgel	  platform	  can	  be	  applied	   to	   the	   production	   of	   any	   gene	   that	   does	   not	   require	   significant	   post-­‐transcriptional	  modifications,	  yet	  each	  gene	  may	  require	  different	  gel	  conditions	  for	  optimal	  expression.	  The	  original	  P-­‐gel	  work	  demonstrated	  the	  production	  of	  various	   functional	   proteins	   in	   wheat	   germ	   lysate,	   although	   I	   did	   not	   achieve	  sufficient	   levels	   of	   mCherry	   expression	   to	   continue	   work	   using	   fluorescence	  microscopy.	   A	   possible	   reason	   behind	   this	   difference	   between	   expression	   from	  GFP	   and	  mCherry	   is	   that	   the	   genes	  may	   operate	   differently	   under	   differing	   X-­‐DNA:gene	  ratios.	  Similar	  to	  the	  original	  work	  that	  demonstrated	  an	  optimal	  ratio	  for	   GFP	   in	   the	   plasmid	   pIVEX1.3,	   it	   appears	   that	   expression	   of	   different	   genes	  may	   require	   further	   optimization	   regarding	   the	   amount	   of	   X-­‐DNA	   used	   in	   gel	  formation;	  this	  can	  be	  further	  tested	  with	  an	  array	  of	  different	  proteins.	  Further	  insight	   into	   these	   mechanisms	   will	   potentially	   allow	   for	   better	   control	   over	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genotype-­‐phenotype	   connection,	   as	   control	   over	   expression	   levels	   can	   aid	   in	  ensuring	  proteins	  have	  sufficient	  nickel	  binding	  sites	  on	  their	  associated	  microgel	  and	  thus	  reducing	  their	  free	  diffusion	  to	  gels	  containing	  other	  gene	  sets.	  	   The	  major	   thrust	  of	   this	   thesis	   is	   to	  demonstrate	   that	   in	   the	   field	  of	  cell-­‐free	   protein	   synthesis,	   DNA	   materials	   offer	   multiple	   avenues	   for	   tailoring	   a	  platform	  for	  protein	  expression	  and	  capture	  that	  is	  not	  achievable	  through	  other	  materials.	   There	   is	   much	   left	   to	   explore	   and	   optimize	   within	   the	   realm	   of	  possibilities	   presented	   in	   this	   work.	   Application	   of	   these	   methods	   to	   gene	  selection	   and	   ensuring	   genotype-­‐phenotype	   connection	   within	   DNA	   gels	   is	   the	  next	   logical	   step	   in	   this	   process,	   presenting	   an	   entirely	   in	   vitro	   method	   of	  exploring	   full	  mutation	  spaces	   in	   the	  engineering	  and	  discovery	  of	  new	  protein	  activity.	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